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Abstract
Techno-economics of Industrial Scale
β-D-fructofuranosidase and Short-chain
Fructooligosaccharides Production
MP Shedlock
Department of Industrial Engineering
University of Stellenbosch
Thesis: MEng (Engineering Management)
March 2014
Enzymes are proteins which act as biological catalysts to enhance the rate
of biochemical reactions. They function by reducing the activation energy
of the reaction. There is currently no company that manufactures enzymes
on an industrial scale in South Africa. A substance known as short-chain
fructooligosaccharide (scFOS) is a product that has been growing in popularity
on the prebiotics market. ScFOS is produced with an enzyme called β-D-
fructofuranosidase (FFase) and sucrose. FFase is a speciality enzyme which
is specifically manufactured for scFOS production. FFase can be produced
with the choice of two different recombinant yeast-based production systems,
where both were compared in this study. Regarding sucrose sugar supply,
South Africa’s sugar industry has export sugar that would be more beneficial
to supply locally because of unattractive international sugar prices, where raw
sugar is essentially sold at a loss. This makes for a good opportunity to produce
scFOS.
iii
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ABSTRACT iv
In this study, an economic model was developed as a tool to determine the
economic feasibility of producing FFase and scFOS on a commercial scale loc-
ally. The model considered different production scales in order to meet differ-
ences in market demand. The facility focused on the production of FFase and
scFOS. Scenarios were investigated where FFase is: (i) manufactured within
the same plant as scFOS production, (ii) manufactured in a separate facility
and bought in by the scFOS production facility, and (iii) manufactured in a
toll manufacturing facility and supplied to a scFOS production facility.
When comparing the two production strains to produce FFase, alcohol ox-
idase (AOX) was found to be more effective than glyceraldehyde 3-phosphate
dehydrogenase (GAP). The simulation results incorporating Monte Carlo ana-
lysis revealed that FFase should be sold as a product within a multi-product
enzyme facility and not as a facility on its own because the demand for this
enzyme alone is too low and will therefore not provide enough sales to sus-
tain the business. To achieve the desired internal rate of return on investment
(minimum of 30%) scFOS could be produced on an appreciable scale in South
Africa at a minimum of 2 000 tonnes per annum irrespective of the scenario.
For an scFOS production facility to be successful, it is recommended that
FFase and scFOS are produced in the same facility.
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Uittreksel
Tegno-ekonomie van Industriële Skaal
β-D-fruktofuranosidase en Kort-ketting
Fruktooligosakkariede Produksie
(“Techno-economics of Industrial Scale β-D-fructofuranosidase and Short-chain
Fructooligosaccharides Production”)
MP Shedlock
Departement Bedryfsingenieurswese
Universiteit van Stellenbosch
Tesis: MIng (Ingenieursbestuur)
Maart 2014
Ensieme is proteïene wat as biologiese katalisators optree, wat die tempo
van biochemiese reaksies bevorder. Die grondslag van die ensiem se funksie
is om die aktiveringsenergie van die reaksies te verlaag. Tans is daar geen
maatskappy in Suid Afrika wat ensieme op industriële skaal vervaardig nie.
Kort-ketting frukto-oligosakkariede (kkFOS) is ’n verbinding waarin die pre-
biotiese mark toenemende belangstelling toon. Die kkFOS kan vanaf sukrose
geproduseer word in ’n reaksie wat deur die ensiem β-D-fruktofuranosidase
(FFase) gekataliseer word. FFase is ’n spesialiteit ensiem wat pertinent vir
die produksie van kkFOS vervaardig word. Dié ensiem kan deur twee rekom-
binante gis-gebaseerde produksiesisteme geproduseer word, en beide sisteme
is in hierdie studie ondersoek. Met verwysing na die sukrose suiker aanbod,
Suid Afrika het groot volumes suiker wat vir die uitvoermark bestem is, maar
weens hoë internasionale suikerpryse word die suiker effektief teen ’n verlies
v
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UITTREKSEL vi
verkoop. Plaaslike produksie van kkFOS mag dus meer aantreklike geleent-
hede bied wat tot voordeel van die plaaslike ekonomie aanwend kan word. ’n
Ekonomiese model is in hierdie studie ontwikkel wat as instrument kon dien
om die ekonomiese haalbaarheid van plaaslike FFase en kkFOS produksie op
kommersiële skaal vas te stel. Die gesimuleerde fasiliteit kom beide FFase en
kkFOS produseer. Verder het die model verskillende skale van produksie in
ag geneem, en sodoende kon die effek van verskille in die aanvraag om die
produk gesimuleer word. Die volgende scenario’s vir FFase produksie is on-
dersoek: (i) produksie in dieselfde aanleg as vir kkFOS produksie, (ii) ensiem
word vanaf ’n onafhanklike vervaardiger aangekoop wat dan in ’n ander aan-
leg vir kkFOS vervaardiging gebruik word, en (iii) die ensiem word deur ’n
tol-vervaardigingsaanleg aan die kkFOS aanleg verskaf. ’n Vergelyking tussen
twee produksiesisteme het getoon dat die alkohol-oksidase (AO) sisteem meer
doeltreffend vir FFase produksie aangewend kon word as ’n sisteem wat op
gliseraldehied 3-fosfaat dehidrogenase (GAP) gebaseer was. Die resultaat van
die simulasies, met Monte Carlo analises geïnkorporeer, het daarop gedui dat
FFase in ‘n meervoudige produk aanleg vervaardig moet word, en nie in ’n
aanleg wat slegs op FFase produksie gebaseer is nie. In so ’n enkel-produk
aanleg is die vraag na die ensiem nie groot genoeg om die besigheid volhou-
baar te maak nie, aangesien die mark nie die nodige verkope sal kan ondersteun
nie. Om die teiken interne opbrengskoers van minstens 30% te bereik, moet
kkFOS op ’n aanvaarbare skaal van ten minste 2 000 ton per jaar vervaardig
word, ongeag van die scenario waarin dit geproduseer word. Vir die suksesvolle
produksie van kkFOS word dit aanbeveel dat FFase and kkFOS in dieselfde
aanleg geproduseer word.
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Glossary
Expression Description
1-F-fructofuranosyl nystose a carbohydrate sugar consisting of 4 parts fructose and 1 part glucose
β-D-fructofuranosidase an enzyme with hydrolase and transferase activity
Antigenic a substance that promotes the production of an antibody when intro-
duced into the body (TheFreeDictionary, 2012)
Chromosome a strand of DNA that contains hereditary information that is essential
for the life of a cell (TheFreeDictionary, 2012)
Cytotoxic substances that are toxic to cells (TrueKnowledge, 2012)
Eukaryote a domain above the kingdom that includes organisms that have one or
more cells containing visible nuclei and organelles (Merriam-Webster,
2012)
Exon a sequence of DNA that codes information for the synthesis of protein
that is transcribed to the messenger RNA (TheFreeDictionary, 2012)
Fructohydrolase an alternative name for β-D-fructofuranosidase
Fructooligosaccharide a polysaccharide comprised of one glucose molecule and and range
between two and four fructose molecules
Fructose a monosaccharide sugar
Fructosidase an alternative name for β-D-fructofuranosidase
Fructosyltransferase a variant enzyme of β-D-fructofuranosidase
Gene a segment of DNA coding for an RNA molecule’s sequence (Bailey and
Ollis, 1986)
Glucose a monosaccharide sugar
Heterologous something that is immunologically related but not identical (TheFree-
Dictionary, 2012)
Hydrolysis a chemical reaction where water reacts with a compound to produce
other compounds; it involves the cleaving of a bond and the adding of
the hydrogen cation and the hydroxide anion from the water (TheFree-
Dictionary, 2012)
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Expression Description
Intron a section of a gene that exists between exons that is removed before
translation of messenger RNA and does not function in coding for pro-
tein synthesis (TheFreeDictionary, 2012)
Inulase a β-D-fructofuranosidase variant (Grootwassink and Fleming, 1980)
Invertase an alternative name for β-D-fructofuranosidase (Swiss Institute of
Bioinformatics, 1998)
Kestose a carbohydrate sugar consisting of 2 parts fructose and 1 part glucose
Methylotrophic an organism that is able to use methanol as the sole carbon and energy
source (Faber et al., 1995)
Nucleoside a glycoside formed by partial hydrolysis of a nucleic acid (WordNet,
2012)
Nucleotide phosphoric ester of a nucleoside; the basic structural unit of nucleic
acids (DNA or RNA) (WordNet, 2012)
Nystose a carbohydrate sugar consisting of 3 parts fructose and 1 part glucose
Periplasm the area in a gram-negative bacterium between the plasma membrane
and a surrounding membrane that contains mostly enzymes and a thin
layer of peptidoglycan (Merriam-Webster, 2012)
Peroxisome a membrane-enclosed organelle that contains enzymes that are involved
in a different variety of metabolic reactions, which include several as-
pects of energy metabolism (Cooper, 2000)
Plasmid an additional small piece of DNA which is found in many bacteria and
eukaryotes (Bailey and Ollis, 1986)
Promoter a promoter is a region in DNA that facilitates the transcription of a
particular gene under particular conditions
Proteolytic An enzyme that stimulates proteolysis, which is the splitting of proteins
by hydrolysis (Biology-Online, 2005)
Recombinant a series of procedures that are used to recombine DNA segments. A
recombinant DNA molecule is constructed from the segments of two or
more different DNA molecules. Under certain conditions, a recombin-
ant DNA molecule can enter a cell and replicate there, either on its
own or after it has been integrated into a chromosome (MedicineNet,
1996-2012)
Ribosome biochemical reaction sites for protein synthesis (Bailey and Ollis, 1986)
Splicing the process of preparing recombinant DNA (Merriam-Webster, 2012)
Sucrase an alternative name for β-D-fructofuranosidase
Sucrose a di-saccharide sugar consisting of one fructose molecule and one glucose
molecule
Transcription making an RNA (ribonucleic acid) copy from a sequence of DNA
(deoxyribonucleic acid) (a gene) (MedicineNet, 1996-2012)
Transfructolysation the action that the enzyme of β-D-fructofuranosidase takes on sucrose
Translation the step in gene expression where the information contained in the
nucleotide sequence of a messenger RNA molecule is used to direct the
synthesis of a peptide chain with a corresponding amino acid sequence
(Bailey and Ollis, 1986)
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Chapter 1
Introduction and Theoretical
Framework
1.1 Industrial Enzymes and ScFOS Background
1.1.1 Overview of Industrial Enzymes and ScFOS
Enzymes are important and useful components in biochemical processing. The
challenge is to produce the enzymes to be able to meet the demands of large
scale productions, which is why there is a desire to implement an industrial
enzyme production facility. The present situation in South Africa is that
enzymes that are required for industrial use are imported. The desire is to
develop the local biotechnology industry, where the ideal situation would be
to have an industrial enzyme production facility within the country so that
the enzymes would be available locally and thus hopefully become a cheaper
alternative to importing. The enzyme production facility would also help with
the country’s economy as the facility would create more jobs as labour would
become necessary.
There has been a fair amount of work done in industrial enzyme produc-
tion. This is no surprise as people have been working with industrial enzymes
since the time of man. The main point is that man did not realise they were ac-
tually using the enzymes. There are many countries in the world that produce
enzymes on an industrial scale for the various industries that demand these cer-
1
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tain enzymes. South Africa is a country that does not have an existing facility
and therefore has an interest to see whether one should be implemented.
Enzymes are used in the manufacturing processes of many different products.
These include the medical industry where a lot of vitamins and various other
pharmaceuticals are produced, the food and beverage sector, where enzyme
perform a pivotal role in the manufacturing of beer and wine. Enzymes are
even used in the most unassuming applications such as the production of de-
tergents and the stone washing of jeans, which shows the versatility of enzymes
and shows a good reason why it would be beneficial to have a facility available.
There has been a growing interest in recent times over a product which
is know as scFOS, which stands for short-chain fructooligosaccharide. This
product has become popular in east Asia and there is also a keen interest in the
United States of America and Europe (Charalampopoulos and Rastall, 2009).
There is also an interest with scFOS in South Africa (Personal communication:
Tongaat Hulett Ltd., Tongaat, KwaZulu-Natal, South Africa). This product
is of attention because of its health benefits. The method to produce this
product is by taking raw sucrose and putting it into contact with an enzyme
by the name of β-D-fructofuranosidase. To be able to produce scFOS on a
commercial scale, the enzyme would also have to be available on a large scale
to meet the need of scFOS production.
1.1.2 Production History
ScFOS was first produced in 1984 by Meiji Seika Kaisha Ltd. using the or-
ganism of Aspergillus niger (Vaňková et al., 2008). It was marketed in Japan
using the brand name, ‘Meioligo’. Meiji Seika Kaisha Ltd. later joined up
with a French company, Beghin-Say. Together the FOS’s were produced using
the trademark name, ‘Actilight’ (Yun, 1996). This was followed by its suc-
cessful production in an industrial scale by a South Korean company. Cheil
Foods Chemical Co., using an immobilised of Aureobasidium pullulans (Mad-
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 1. INTRODUCTION AND THEORETICAL FRAMEWORK 3
lová et al., 2000).
Initially scFOS had a low amount of fibre in the product but the fibre
content has gone up to a minimum of 95% (Cho and Terry Finocchiaro, 2009).
Presently, scFOS is marketed under three different brand names: NutraFlora®
in North America, South America and Australia; Actilight® in Europe; and
Meioligo in Asia (Cho and Terry Finocchiaro, 2009). ScFOS has been approved
in Japan as a food ingredient since 1980 and it also has FOSHU (Foods for
Specified Health Uses) status. ScFOS has been recognised in Europe as a
proper food ingredient since 1991 and was commercially available in the United
States in 1988 and has the GRAS (generally recognised as safe) status (Cho
and Terry Finocchiaro, 2009).
There have been further studies where scFOS is produced using fructosyl
transferase (FTase), where the enzyme would perform the same function, but
it would be manufactured in a different manner. There are many different
types of organisms that are available which include different fungi and yeasts.
The goal is to try and find an organism that will allow one to produce the
most amount of enzyme at the lowest costs.
β-D-fructofuranosidase (FFase) is an enzyme that has many variants with
similar functions. The difference is that they are produced in a different man-
ner from each other. FFase is an enzyme that has been produced in countries
where the scFOS market is already well developed such as countries in east
Asia. Grootwassink and Fleming (1980) have shown to produce FFase from
Kluyveromyces fragilis. There is a demand in South Africa for scFOS of approx-
imately 200 tonnes (Personal communication: Tongaat Hulett Ltd., Tongaat,
KwaZulu-Natal, South Africa) and through this interest, this has resulted in
the desire for an industrial scale production of FFase and scFOS.
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1.1.3 Recent Developments
Since 2010, the University of Stellenbosch and Rhodes University began a joint
project in the attempt to produce scFOS. Stellenbosch University performed
research with the production of the enzyme, β-D-fructofuranosidase, which
was used in the scFOS production process. Rhodes University took the enzyme
that Stellenbosch produced and used it in their experiments to optimise the
yield of scFOS. Later, more scFOS experiments were performed at Stellenbosch
to find the best method and determine specific enzyme dosages for scFOS
production.
When speaking about ‘optimising’ the yield of scFOS, the goal was to
produce an scFOS that had the same composition as Actilight®, which is
currently used as the benchmark by other scFOS producers.
1.1.4 Industrial Importance
If one wants to be successful in producing and selling a product such as scFOS;
one needs to be able to market the product and be able to sell enough quantities
so the project can be viable. The scale should be high enough to ensure that
the investment is worthwhile.
The global and local markets were looked at to observe how large the
production scale should be. Sugar, which is the raw ingredient for scFOS
production in the country of South Africa, is a resource that is of abundance
which is good news for scFOS production in South Africa. The other industrial
issue is to be able to produce β-D-fructofuranosidase at a level that meets the
demand for the scFOS production process.
Stellenbosch University has performed lab scale experiments but the chal-
lenge is to produce the enzyme commercially so they are available for sales in
large quantities.
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1.2 Research Proposal
1.2.1 Aim
This project is aimed at the country of South Africa where enzymes are
presently not produced but rather imported. The project can also be imple-
mented in other countries in a similar situation. The project will aim initially
to meet the local market demand of scFOS and hence the required FFase
needed for the production of scFOS. The proposition of the implementation of
a multi-enzyme production facility will be investigated to see if it will be viable.
If this is viable, the process could be scaled up to supply on a national and
international level, benchmarking against the product pioneers Béghin-Meiji
who manufacture Actilight®.
1.2.2 Objectives
The project has certain objectives that it needs to achieve in order for it to be
valuable research so that it may be used for further studies to come and also
for a possibility for an implementation of the project in the country of South
Africa. The research project has the following objectives that are set out to
be achieved:
• The project will investigate if there is potential for the application of
a feasible industrial enzyme production facility in the country of South
Africa.
• The comparison of different scenarios were made. Scenarios were looked
at where FFase was: i) produced in a facility to be sold to scFOS produc-
tion process around the world, ii) manufactured within the same plant
as, and used solely for that scFOS production process, iii) manufactured
in a separate facility and bought in by the scFOS production facility,
iv and manufactured in a toll manufacturing facility and supplied to a
scFOS production facility.
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• An economic model will be built using the appropriate software, that
will determine whether the concept of building an industrial enzyme
production facility in South Africa will be a viable option or not. More
specifically, the minimum scale of scFOS production required to achieve
an IRR of at least 30%.
1.2.3 Deliverables
In order to ensure that the objectives of the project are met, deliverables are
essential to monitor the progress of the research so that the project may stay on
track and be completed within the intended time. The following deliverables
are proposed for the project:
• Develop a standard design for the production of the enzymes as well as
the production process of scFOS using Microsoft Office Visio®.
• Perform a mass and energy balance (using Microsoft Office Excel®) on
the proposed design, to quantify the materials used and produced and to
also determine the units operations that are to be used and the energy
used within the process.
• Perform a costing analysis of the production plant to determine the vi-
ability of producing FFase and scFOS in South Africa.
• Use the software of RiskSim simulation program which is a Microsoft
Office Excel® add-in to analyse the certain risks that are involved with
the construction and running of an enzyme production plant. A full
Monte Carlo simulation will be performed.
• Use Matlab®, mathematical computing software to plot surface plots
from the RiskSim simulation results.
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1.2.4 Research Significance
With the new age of sustainable development, chemical process industries
are looking for new and innovative ways to manufacture products, with a
focus on ‘greener’ methods to produce products. The biotechnology world
has now become a path that has received growing attention as it is an option
where processes can substitute their previously inorganic chemical processes
with organic ones using biological components in order to reduce any possible
environmental harm.
Enzymes are a perfect candidate to replace potentially harmful inorganic
chemicals. The challenge is to be able to produce the enzymes on an appre-
ciable scale. Enzymes are used in many different industries and there is interest
for enzymes to become a replacement in process where previously inorganic
substances were used.
The growing interest of the product of scFOS has become significant in
the sugar industry. If the sugar industry were to use the FFase enzyme, they
could greatly increase the value of their sugar into scFOS just by using the
FFase enzyme. The attractiveness about producing scFOS is that the main
raw ingredient for the process is the raw sugar that is produced from a sugar
mill. This means that no extra purification or refining needs to be done for
the scFOS to be produced.
1.2.5 Thesis Plan
A Gantt chart is drawn up to show the proposed project plan (see figure 1.1).
It is important to note that this plan is an estimation and the duration of some
tasks may be shorter or longer in reality. The intended duration of the entire
research project is as shown in the Gantt chart.
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Figure 1.1: Project plan for the research project showing deliverables and mile-
stones to be completed for the project.
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Chapter 2
Literature Review
2.1 Overview
Enzymes are natural catalysts and their function is to accelerate reactions
that take place in a cell and its surroundings (Kirk et al., 2004). A catalyst
is something which is able to facilitate a chemical reaction, but it will not
undergo any changes itself during the chemical reaction. Therefore an enzyme
will be involved in a biochemical reaction where the enzyme will lower the
activation energy needed to induce the chemical reaction. Enzymes are not
stable and as a result lose their activity after a period of time. For this reason,
there is a need for enzymes to be produced on an industrial level.
Enzymes have shown to be very useful in many different applications ran-
ging from a lot of commercial foods that are sold in shops today which would
include bakery products, alcoholic beverages, dairy products, fruit juice and
textile industries to name a few (Vroemen, 1983). Enzymes are also used in
other different applications such as dishwashing detergents, pulp and paper
production and leather tanning (Enzyme Technical Association, 2001).
Enzymes are basically broken up into different categories according to their
function and the compounds that they react with. They are named according
to their biochemical reactions they catalyse. To name a few: proteases are
enzymes that break down proteins, cellulases break down cellulose, lipases
divide lipids (fats) into glycerol and fatty acids, and amylases are responsible
9
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for breaking down starch into simple sugars (Enzyme Technical Association,
2001).
It can be seen that enzymes form a very important part of the production
process of many simple and complex products needed for everyday living. The
fact that the enzymes are used for these everyday needs (e.g. dishwashing
detergent) shows that there is a need to produce the enzymes on a large scale,
otherwise the product would not be able the contend with the demands of the
public. This gives support to the idea for the implementation of industrial
scale production. One of the main reason driving large scale of production is
economies of scale and the ‘six tenths rule’, which is explained in more detail
further on in this document. A challenge is to be able to find or develop a big
market to be able to sustain a facility of a large size.
Enzymes are usually acquired through the sources of animal tissue, mi-
crobes and plant material (Enzyme Technical Association, 2001). The only
problem with the acquisition of enzymes in the manner of using plants and
animal tissue is that it is difficult to produce enzymes in large quantities. If
microbes are used; it is possible to produce the enzymes in larger quantities.
The conditions for growing the organism need to be favourable so that there
is prolific population growth.
This points again to large scale enzyme production. With industrial enzyme
production; the desire is to be able to produce quantities of enzyme that are
enough to meet the market demand. Industrial enzymes are pitched at different
prices according to different demands. In this work, they will be divided into
three categories.
1. Commodity enzymes: High demand, low price
2. Intermediate enzymes: Medium demand, average price
3. High value enzymes: Low demand, high price (i.e. speciality enzymes)
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The ideal situation would be if South Africa had an enzyme production
facility that produced the enzymes locally, which in time would become a
more economical option, for industries who need enzymes, than to import the
enzymes from overseas countries. A question that would arise would be: does
one focus on a production facility that produces enzymes from one category?
For example, would it be more worthwhile to have a facility that produces
only commodity enzymes? Or would it be better to have a facility that has
multiple products, namely commodity, intermediate and high value enzymes
all being produced in the same plant?
The initial thinking is that the original start-up cost of these facilities
would be fairly similar. Equipment costs for the different types of enzymes
may vary slightly, but their production method would use similar if not the
same techniques. The next factor to think about is when will the facility be
able to pay back the initial investment used to start up the plant? How will the
three categories compare to each other in this respect as the three categories
are different in their demands and prices? The controlling factor is obviously
the price and the demand of the products as mentioned.
A big factor that plays a role in the construction of a plant is the idea of
economies of scale which is linked with the ‘six tenths’ rule. The ‘six tenths’
rule shows that when the cost attribute of the piece of equipment increases,
the cost of the the piece of equipment only increases by the power of six
tenths as opposed to a linear increase. This essentially means that as the
scale of production increases, the size of equipment would need to increase.
When the size increases, the cost increases by a power of six tenths, which has
the following effect: as the production output increases, the relative cost of
equipment decreases for increasing production output. This means that the
business will experience an economy of scale.
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2.2 Previous Work
2.2.1 Enzymes
Enzymes have been present since cheese manufacturing and indirectly via
yeasts and bacteria in food production. In 1914, isolated enzymes were used
in detergents. Enzyme’s protein nature was proven in 1926 and large-scale
microbial production began in the 1960s (Leisola et al., 2001). Enzymes are
types of proteins that have a unique function of catalysing certain biochemical
reactions, depending on the type of enzyme. They are crucial for the mainten-
ance and development of life (Kirk et al., 2004). They are natural catalysts
and are composed of up to 20 different amino acids (Kirk et al., 2004).
The Enzymes are important for all metabolic processes, although they are
not living (Enzyme Technical Association, 2001). The enzymes are made up
of amino acids like all other proteins are, but the difference is shown in their
catalytic ability, which makes them exclusive. Table 2.1 gives some examples
of large scale enzyme applications.
2.2.1.1 Enzyme Preparation
The commercial types of enzymes are acquired from three primary sources:
animal tissue, plants and microbes. These enzymes that occur naturally can
typically cater for small amounts and are not enough for industrial applica-
tions, however, there is a way to select the best genetic strain and optimise
the cultivation conditions with the preferred strain to get the desired output.
Fermentation is the technique that is used to produce the enzyme and there-
after, the microorganisms are killed and the enzymes are separated, and can
thus be used for industrial applications (Enzyme Technical Association, 2001).
2.2.1.2 Advantages of Enzymes
Using enzymes as opposed to normal chemical treatment can be very benefi-
cial. Enzyme Technical Association (2001) says that the use of enzymes can
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Table 2.1: Large scale enzyme applications (Leisola et al., 2001)
Industry Enzyme Effect
Detergent proteinase protein degradation
lipase fat removal
cellulase colour brightening
Textile cellulase microfibril removal
laccase colour brightening
Animal feed xylanase fibre solubility
phytase release of phosphate
Starch amylases glucose formation
glucose isomerase fructose formation
Pulp and paper xylanase biobleaching
Fruit juice pectinase juice clarification
cellulase juice extraction
xylanase juice extraction
Baking xylanase dough conditioning
α-amylase loaf volume; shelf-life
glucose oxidase dough quality
Dairy rennin protein coagulation
lactase lactose hydrolysis
Brewing glucanase filter aid
papain haze control
improve the quality of products while lowering the manufacturing cost of the
item. Less waste will be produced and also the energy use can be decreased.
It is stated further by Enzyme Technical Association (2001) that traditional
chemical treatments are sometimes harder to control, and have the possibil-
ity of creating some extreme conditions. Another shortcoming of traditional
chemicals is that they tend to produce unwanted waste and by-products. En-
zyme use can be controlled very well with the appropriate dosage, the correct
operating temperature and the time. The fact that the enzymes act as cata-
lysts means that only a small amount of the enzyme needs to be added in order
for the reaction to proceed. The enzymes that were used in the food industry
are usually terminated during the downstream process and thus do not exist
in the food product (Enzyme Technical Association, 2001).
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2.2.1.3 General Enzyme Production
The generic enzyme production process is shown in Figure 2.1. The simple
illustration shows the basic idea behind commercial enzyme production.
Figure 2.1: Enzyme production process illustration (Redrawn) (EuropeanPro-
ject(FP6), 2011).
The process simply begins with a cell growing in a small Petri dish. After
the cell has increased its population to a stable amount, the cells are then
transferred to shake flasks where they have a larger volume and cell mass to
grow further. From the shake flask the medium is taken to a fermenter, where
the cells are contacted with air and allowed to ferment. Once fermentation has
been completed, the cells are removed, the enzymes that have been produced
after fermentation are refined, where the procedures of concentration, modific-
ation and purification are done. It is important to know whether the enzymes
will be transported and stored in the liquid form or powder form. In this way,
from the refining step in the process the enzymes are either sent to a mixing
and blending section, where the product is in the liquid phase, or the enzymes
are sent to a drier, where the final product is in the form of a powder. From
here the products are stabilised and are treated with preservatives before they
are transported.
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2.2.2 Pichia Pastoris
Pichia pastoris is a yeast that has been chosen as the host strain for the
production of β-D-fructofuranosidase in this project. Cereghino and Cregg
(2000) say that P. pastoris, the methylotrophic yeast, has developed into a very
successful scheme for producing a selection of different heterologous proteins.
The reason, Cereghino and Cregg (2000) says that P. pastoris is becoming so
popular is because of the following factors:
1. The methods necessary for molecular genetic modification of P. pastoris
are very simple and also P. pastoris has shown to have very similar traits
to S. cerevisiae, which is one of the best developed experimental systems
in present day biology.
2. P. pastoris has a capability to produce foreign proteins in large amounts,
where is it both intracellular and extracellular.
3. The P. pastoris also has the ability to undergo eukaryotic post-translational
changes, which include glycosylation, disulphide bond formation and pro-
teolytic processing.
4. The expression system of the P. pastoris is readily available as a com-
mercially bought kit.
2.2.2.1 The Gene Expression Process
Gene expression is a complex process whereby the information supplied by a
gene is utilised in the creation of a functional gene product. The products
formed are proteins. Gene expression is used by all known life - eukaryotes
(which includes organisms that are multicellular), prokaryotes (which include
bacteria and archaea) and viruses (News-Medical, 2012).
The expression of a gene to form the sequence of amino acids and sub-
sequent protein happens in a two-step process. The first step in the gene
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expression process is known as transcription (see figure 2.2) where an enzyme
called RNA polymerase acts as the catalyst and synthesises the mRNA mo-
lecule using the gene as a template. Step two of the gene expression is known
as translation. This step uses the information that exists in the nucleotide
sequence of an mRNA molecule to direct the synthesis of a peptide chain with
a corresponding amino acid sequence (Bailey and Ollis, 1986).
Figure 2.2: Gene expression to produce a protein (Redrawn) (News-Medical, 2012).
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2.2.2.2 Promoters
In order for the P. pastoris to be able to develop and express a certain gene
within itself, the correct promoter needs to be chosen. A promoter is a region
in DNA that facilitates the transcription of a particular gene under particular
conditions (figure 2.2). From there the enzyme (in this case FFase), which is
regarded as the protein (figure 2.2), starts to be produced.
There are a few promoters that can be chosen for the expression of a specific
gene in P. pastoris, namely AOX, GAP, FLD1, PEX8, and YPT1 (Cereghino
and Cregg, 2000). Table 2.2 gives a more detailed explanation of the promoters.
Table 2.2: Various promoters that can be used for the P. pastoris gene expression
system
Expression Description
AOX alcohol oxidase (Cereghino and Cregg, 2000)
GAP glyceraldehyde 3-phosphate dehydrogenase (Cereghino and Cregg,
2000)
FLD1 formaldehyde dehydrogenase (Macauley-Patrick et al., 2005)
ICL1 isocitrate lyase (Macauley-Patrick et al., 2005)
PEX8 an intraperoxisomal peroxin of Saccharomyces cerevisiae required for
protein transport into peroxisomes binds the PTS1 receptor Pex5p
(Rehling et al., 2000)
YPT1 a yeast gene encoding a protein homologous to the human c-has/bas
proto-oncogene product (Gallwitz et al., 1983)
According to Cereghino and Cregg (1999), AOX was a popular promoter
from the options presented (see table 2.2) for the P. pastoris expression system
where it was successfully used to produce over 300 foreign proteins. Lin Cereghino
et al. (2001) further state that compared to other fungi, the benefit of the P.
pastoris expression system is the use of an unassumingly effective and closely
monitored promoter derived from AOX. Cereghino and Cregg (2000) explain
that although the AOX has been a successful promoter in the expression sys-
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tem, there are some situations where AOX has not been the most appropriate
promoter. The AOX needs to be induced by methanol, and for this reason,
as scFOS is a product that is for human consumption, the level of methanol
that could possibly carry over in the scFOS process could cause the scFOS to
be potentially harmful to the people buying the product.
Another negative factor about using AOX is that methanol is a potential
fire hazard as the substance is flammable and therefore if one were to use AOX,
they would have to put safety measures in place, which would cost extra money
and training, which is undesirable. The desire is to find a promoter that does
not have to be induced so that no extra components have to be added to the
system.
One promoter that serves as a very good alternative to AOX, is GAP.
GAP has shown to be a very good constitutive promoter. What is meant
by constitutive is that it does not need to be induced, or ‘switched on’, but
instead from the start of inoculation, the GAP allows the production of the
enzyme to happen, the gene expression happens from the start. GAP does not
need methanol for induction. A downside to using GAP, however is that it
does not cause the yeast of P. pastoris to produce as much protein (enzymes)
as AOX does. Another disadvantage of GAP is that due to the fact that it
expresses in a constitutive manner, it is not a advisable option when producing
proteins that are toxic to the yeast (Cereghino and Cregg, 2000). This is
backed up by Menendez et al. (2004), where it is stated that GAP has not
been used extensively because it is believed that constitutive production of
foreign proteins in P. pastoris could have cytotoxic effects.
FLD1, according to Veenhuis et al. (1983) is a very important enzyme
that is used in the metabolic pathway in P. pastoris. FLD1 promoter initi-
ates the expression of a glutathione-dependent formaldehyde dehydrogenase,
which is an important enzyme that is needed to metabolise certain methylated
amines as nitrogen sources and methanol as a carbon source (Shen et al., 1998).
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Cereghino and Cregg (2000) mentions that FLD1 can be induced with meth-
anol as its carbon source with ammonium sulphate as the nitrogen source, or
methylamine as a sole nitrogen source and glucose as the carbon source. Once
induction has occurred, with the methanol or methylamine, FLD1 has the
ability to express certain levels of a β-lactamase reporter gene, which shows
similarity to those acquired with methanol induction from the AOX1 promoter.
The benefit of the FLD1 promoter is that it offers the flexibility to be able
to induce high levels of expression using either the methanol or methylamine,
which shows to be an inexpensive nitrogen source that is also non-toxic. This
is confirmed by Shen et al. (1998), where it is claimed that FLD1 is involved in
protecting the cell from toxicity, which is caused by the formaldehyde during
the methylamine metabolism.
AOX1, GAP and FLD1 are not always the most appropriate promoters for
the given expression system. Sometimes, the aforementioned promoters are
too strong, where they express the genes at a level that is too high. Brierley
(1998) and Thill et al. (1990) have shown that for some specific foreign genes,
the high level of expression from AOX1 may damage the physical morphology
of the cell after translation and will cause major part of the foreign protein
to be misfolded, unprocessed, or mislocalised. For this reason, the promoter
of PEX8 is introduced, as it is not as ‘harsh’ as the previous three that have
been mentioned. PEX8 encodes a peroxisomal matrix protein that is vital
for the biogenesis of the peroxisome (Liu et al., 1995). The gene expresses
itself at a low but substantial level and induction occurs when the cells are
shifted to methanol. Segev et al. (1988) states that the YPT1 gene encodes
a GTPase involved in secretion, and its promoter offers a low but constitutive
level of expression in media containing glucose or methanol or mannitol as the
available carbon sources.
ICL1, which is a gene of P. pastoris, was investigated as another option
as a promoter to the regularly used AOX1 and GAP promoters (Menendez
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et al., 2003). Macauley-Patrick et al. (2005) explains further that a plasmid
(pPICLDEX) that contains a single copy of the gene (which was controlled by
ICL1 that encodes dextranase from Penicillium minioluteum was converted
to P. pastoris. High levels of dextranase yield was obtained when the culture
contained a lower level of glucose or ethanol as the sole carbon source. On
the contrary, a higher amount of dextranase was produced when there was no
glucose available than after induction with ethanol. Macauley-Patrick et al.
(2005) concluded that more work needed to be done on the promoter of ICL1
to determine whether it is suitable and practical for the heterologous protein
production in P. pastoris.
Many promoters are available for the expression of the yeast P. pastoris
(Table 2.2). It is important that the most appropriate promoter for the job
is chosen as each promoter has its advantages and disadvantages. For this
project, the two promoters that were chosen were AOX and GAP. The AOX
gene production system was chosen in this project because it has the ability
to produce higher amounts of enzyme protein. A disadvantage of using AOX
is that it needed to be induced by methanol, which is a component that is
a potential fire hazard, and this is not ideal in large scale production as one
would have to have safety precautions for it.
GAP on the other hand, is another useful promoter that is appealing as
it is known as a constitutive promoter, and it therefore does not need to be
induced (Waterham et al., 1997). This means that a hazardous substance such
as methanol would not need to be part of the process and therefore would not
be a cause of concern in the facility. The negative of using GAP is that it
does not promote as much protein formation compared to AOX. The choice of
promoter depended on the economics of the process, i.e. which will be a more
beneficial option with regard to cost.
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2.2.3 FFase and scFOS Production
Short chain fructooligosaccharide (scFOS) is a chemical that is regarded as
a pre-biotic, and is used as a food supplement to improve dietary health in
humans. As fructooligosaccharides are found in various fruit and vegetables,
they have also shown to be consumed by animals, measured by an ion chro-
matographic method (Campbell et al., 1997). Table 2.3 shows the chemical
name, the abbreviated name as well as the molecular formula and the molecu-
lar weight of the different constituents that make up the chemical structure of
scFOS (figure 2.3).
Figure 2.3: Illustration of the polysaccharides that make up scFOS (Redrawn)
(Shenzhen Victory Biology Engineering Co., 2011).
Vaňková et al. (2008) did work on the design and economics of industrial
production of fructooligosaccharides (FOS), where the study proposed two
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alternative processes for the production on 10 000 tonnes of FOS’s every year.
The different processes included the production of the FOS in the form of a
powder as well as the FOS in the form of a syrup. The economic analysis by
Vaňková et al. (2008) included the costs for all the pieces of the equipment in
their design as well as prices of the raw materials in the process, which include
the sugar needed (sucrose), the host strain that is used in the process, which is
used to produce the enzyme (FTase) and all other utility costs. Vaňková et al.
(2008)’s production method used the enzyme of FTase where the enzyme is
produced intracellularly. To obtain the enzyme in this case, the cells needed
to be broken open. In this study, the enzyme of FFase was used where in this
case, the enzyme was produced extracellularly. The enzyme existed within the
supernatant.
Table 2.3: Components involved in the scFOS production
Chemical name Abbreviated name Molecular formula Molecular weight
Glucose G C6H12O6 180 g/mol
Fructose F C6H12O6 180 g/mol
Sucrose GF C12H22O11 342 g/mol
Kestose GF2 C18H32O16 504 g/mol
Nystose GF3 C24H42O21 666 g/mol
1-F-fructofuranosyl
nystose
GF4 C30H52O26 828 g/mol
A fructooligosaccharide GF5 C36H62O31 990 g/mol
A fructooligosaccharide GF6 C42H72O36 1152 g/mol
A fructooligosaccharide GF7 C48H82O41 1314 g/mol
ScFOS has many benefits for health, and according to Shenzhen Victory
Biology Engineering Co. (2011), the following benefits have been found:
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• Intestinal flora is regulated and the function of the gastrointestinal
region in the body is greatly improved.
• Blood lipid is reduced. This means that the scFOS has proven to
reduce cholesterol in the body as well as the free trans fatty acids and
the blood sugar level balance.
• Synthesis of vitamin intake is enhanced. This implies that the
scFOS can help improve the absorption of important vitamins such as
vitamin B and folic acid that will promote the metabolism in the body.
This can improve the immune system.
• Blood endotoxins are eradicated. This protects the liver and aids
in the prevention of various chronic diseases and cancers.
• The absorption of the minerals of Ca, Mg, Fe, Zn is enhanced
as well as other mineral matters in order to promote body growth devel-
opment against the bone disease of osteoporosis.
• Prevents obesity because the scFOS is not decomposed easily by the
gastric acid and enzymes inside alimentary tract. This makes the scFOS
extremely difficult to be absorbed by the human body. Because of scFOS
has a very low value in energy, it will not cause obesity, and can act as
a very good low energy functional sweetening agent.
• Preventing decayed teeth. The scFOS is not used by the organism
Streptococcus mutans to make the insoluble glucan and the secondary
product, which is acidic. The scFOS will also not offer a base for the oral
microbes’ sediment or corrosion so that decaying teeth can be inhibited.
• Removing of toxins for facial whitening and beautifying. When
the scFOS is taken, the human body can thoroughly clean out the en-
dotoxins to ensure the prevention of facial sores, black spots, freckles,
acnes and age pigments, and to prevent skin against ageing.
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It can be seen from the above list that scFOS would be a desirable product
as it has many benefits to human health in maintaining the various parts
of the body. In order to manufacture scFOS, the main constituents that are
needed are the enzyme, which is β-D-fructofuranosidase (FFase) and the sugar
of sucrose. The process that is of concern is:
a. the production of the enzyme FFase that is imperative for the scFOS
manufacturing process.
b. the production of scFOS using FFase as the all important enzyme for
the process as well as sucrose.
Vaňková et al. (2008) proposed a design of a fructosyltransferase (FTase)
production facility as well as a FOS production design. The design synthesises
the FTase production and FOS production, where it can be shown that the
raw materials are the input parameters to the process. The design shows the
units the materials pass through, all the way until the FOS production process
is met. The final product comes out as the FOS, which is the desired product.
The goal of the study done by Vaňková et al. (2008), which is entitled
‘Design and economics of industrial production of fructooligosaccharides’ was
to develop a process flow diagram and from this, investigate the viability of
the industrial production of the FOS, for an annual production rate of 10 000
tonnes. This study was based on laboratory and semi-pilot scale experiments
(Vandáková et al., 2004). The FOS’s production was performed in a packed
bed reactor (PBR) and immobilised FTase was used, which was produced
from A. pullulans (Onderková et al., 2007). Gramblička and Polakovič (2007)
determined the distribution coefficients and adsorption data that was needed
for the design of the simulated moving bed (SMB) separation. From here
Vaňková et al. (2008) stated that the material and energy balances as well as
the equipment sizing and costing was done for a few different structures, where
different sucrose sources and end products phases were considered.
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FOS’s are present in various kind of vegetables and some plants. These
include bananas, asparagus, onions, artichokes, shallots and wheat to name a
few (Flamm et al., 2001), (L’homme et al., 2003). Vaňková et al. (2008) says
that FOS’s are produced industrially in two different manners, which results in
two different products. The first process uses the degradation of inulin when
the products are not fructo-oligomer chains any more (Franck et al., 2002).
The second process transforms sucrose by using the enzyme of FTase, which is
obtained from bacterial and fungi sources (Bekers et al., 2002), (Ghazi et al.,
2007), (L’Hocine et al., 2000), (Sangeetha et al., 2004). This is basically a case
of hydrolysis versus synthesis.
Chien et al. (2001), Sangeetha et al. (2005a), Sangeetha et al. (2005b) and
Tanriseven and Aslan (2005) have all made notable contributions with the
research of FOS production. Many different organisms have been used when
producing the enzymes needed for FOS production. Such examples of organ-
isms that have been used are Aureobasidium pullulans, Aspergillus japonicus,
Aspergillus niger and Pichia pastoris (Sánchez et al., 2008). Lee et al. (1992)
and Nguyen et al. (2005) say that during the production of FTase, the type
of organism used during the production the enzyme had a strong influence in
the outcome when cultivating, isolating and purifying the FTase.
Sangeetha et al. (2005c) found that when producing FOS, a yield of 53%
(gram FOS per gram of sucrose) was obtained when using recycled pellets of
Aspergillus oryzae CFR 202. The downside to this however was that the pellets
lost their compactness and started to break up after the sixth cycle. FTase in
the soluble form, in some applications, resulted in some disadvantages such as
loss of enzyme activity during operation. After the conversion occurred, the
enzyme needed to be destroyed as fructose began to form, which affected the
activity (L’Hocine et al., 2000).
Continuous processing is preferred with the enzyme being immobilised as
the better option. The production of FOS’s from sucrose in continuous re-
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actors was done by Won Yun et al. (1997) where the cells of the organism
Aureobasidium pullulans was used as well as enzymes for two different experi-
ment. The cells and enzymes were immobilised on a highly porous resin. These
experiments resulted in a 57% and 58% yield respectively for each experiment.
Jung et al. (1989) says that the stoichiometry of the reaction of FTase and
the sucrose, occurs with a two path parallel reaction mechanism. Furthermore,
Aboudzadeh et al. (2006) mentions that a disproportionation reaction occurs
and the FOS’s and glucose (by-product) form from the activity of the FTase.
The enzyme’s hydrolytic activity causes the formation of the by-products of
glucose and fructose. Sangeetha et al. (2004) found that chemical composition
of the reaction mixture of FOS’s, glucose, fructose and sucrose corresponded
to mass percentages of 65%, 25%, 5% and 5% respectively. Nishizawa et al.
(2001) and Yun et al. (1994) wanted to increase the amount of FOS’s in the
mixture by attempting to remove the glucose from the chemical mixture by
employing an enzymatic reaction. Glucose has been found to inhibit FOS
formation, which is the reason for the glucose removal (Yun, 1996).
After enzymatic reaction, FOS’s are purified and it was found by Crittenden
and Playne (1996), Charton and Nicoud (1995), Kim et al. (1992), Takahashi
and Goto (1994) and Vente (2004) that a good way to concentrate the FOS’s
was to simulate them under moving bed chromatography. Aydoğan et al.
(1998) and Goulas et al. (2002) used the technique of membrane filtration to
concentrate the FOS’s although it came at the expense of low selectivities and
significantly higher costs.
2.2.3.1 Factors Affecting scFOS Production
Like all chemical reactions and chemical reactors, the conditions of the the
inputs and the conditions of the unit operations will determine the state of
the output or the product of the reaction and this is no different for scFOS
production. The conditions of scFOS production have already been discussed
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so there is a good idea as to what are the most common conditions that are
used in industry.
Temperature is a parameter that is very sensitive when chemical reactions
occur. It can be seen, according to the results obtained in the patent by
Muramatsu et al. (1994) that the most favourable conditions for high scFOS
production are around 55◦C and 60◦C (Figure 2.4). The desire is to increase
the concentration of the short-chain fructooligosaccharides while keeping the
concentration of the other components low so the the scFOS percentage is
highest.
Figure 2.4: The effect of reaction temperature on the formation of scFOS
(Muramatsu et al., 1994).
Muramatsu et al. (1994) also published data with regard to the relationship
between the incoming sucrose concentration and the composition of the sugars
that were formed in the reactor (Figure 2.5). The GF2-4 showed to be highly
dependent on the sucrose concentration as it increases substantially from 5%
to 25% as the sucrose concentration increases from 1% to 10%. At a sucrose
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concentration of 30% and above, higher levels of scFOS (GF2-4) production
are achieved (see figure 2.5).
Figure 2.5: The effect of initial sucrose concentration on the formation of scFOS
(Muramatsu et al., 1994).
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2.2.4 Literature Process Design
Vaňková et al. (2008) proposed a design for the production of FOS (Figure
2.6). In Vaňková et al. (2008)’s design the enzyme of fructosyl transferase
(FTase) is first produced. FTase is an alternative enzyme to FFase, where
FTase is simply produced in a different manner to FFase, but performs the
same function. The most important section is shown in Figure 2.6, where the
FOS is produced. The FTase was produced by A.pullulans and it was the
FTase that acted as the biocatalyst for the production of the FOS’s from the
sugar, sucrose. The FTase was present while the cells were cultivated in the
periplasmic space of the cells and also in the cultivation medium (Vaňková
et al., 2005).
Onderková et al. (2007) described details of the processes of cultivation,
separation and purification of the soluble FTase in their study, where it forms
part of the initial section in Figure 2.6. The first section of the process flow
diagram, is the storage tank of V-101, Vaňková et al. (2008) decided that
the cultivation medium, was prepared in the tank V-101 and it consisted of
sucrose, salts and 2% of inoculum. The holding times, temperatures, and
compositions of the process streams involved are all shown in Table D.1. The
cultivation medium that exits out the bottom of tank V-101 and is transferred
via stream 4A to the 10m3 fermentation bioreactor V-102. The purification
and sterilisation of the air (at an average flow rate of 1m3/min) needed for the
cultivation of the medium in R-101 is performed in air compressor C-101 and
the air filter F-101.
When the cultivation is complete in R-101, the medium is sent via stream
5A to the storage/blending tank V-102, where the medium is allowed to sit.
From V-102, the material is sent along stream 6A to the microfiltration unit
F-102, where the cells can be separated from the liquids. The liquid stream
exiting the top of the microfiltration unit F-102, is sent to the ultrafiltration
unit where the medium is separated further for any remaining cells in the liquid
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Figure 2.6: Simplified FTase and FOS production process design adopted from the
design of Vaňková et al. (2008).
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medium. Note, the FTase is present in stream 7A, which flows out the top of
F-102 (filtrate) as well as the stream 15A, which exits at the bottom of F-102
(retentate).
Vaňková et al. (2008) says that to increase the efficiency of the process
to immobilise the cells, the solutes with low molecular mass that exist in the
filtrate (7A), are removed by the ultrafiltration unit (F-103). The concen-
trated cells that exit the ultrafiltration unit F-103, exit via stream 8A and are
processed further in the immobilisation process.
The design that is involved in the work of this thesis will not include an
immobilisation process as the resources available at the University of Stellen-
bosch use a process that does not include the immobilisation process (compare
Figure 2.6 with Figure 2.7). The FTase production design by Vaňková et al.
(2005) also includes a bead milling process which effectively breaks open the
cells so that the enzyme is released into the supernatant.
The design for this project uses the enzyme of FFase, which is produced
differently to FTase and does not need cell breakage and immobilisation. This
is due to the nature of the process where the enzyme is automatically secreted
into the supernatant and the reactor set-up does not allow for cell immobilisa-
tion.
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Figure 2.7: Complete FTase production process design (Vaňková et al., 2008).
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2.2.4.1 ScFOS Reactor Setup
When producing scFOS, there is more than one method of production. One
method of producing scFOS, is to immobilise the enzyme in the reactor in a
packed bed reactor (PBR) setup and let the sucrose flow through the immob-
ilised enzyme to produce the scFOS. Another way is to have the enzyme and
the sucrose to flow into a continuously stirred tank reactor (CSTR) (see Figure
2.8). The reaction is catalysed by the enzyme and the scFOS is the product
formed from the reaction.
Figure 2.8: A schematic diagram of the reactor choice for the scFOS production
process. The choice of the reactor depends on how the enzyme will be used in the
reactor (immobilised or not).
Yun et al. (1992) have suggested that FOS production is more optimal
when using a semi-batch operation compared to a continuously stirred tank
reactor set-up. They mention further that the low yield of FOS’s in the stirred
tank reactor is because of the glucose inhibition that occurred in the reactor.
Glucose inhibition occurs when there is an excess of glucose in the reactor and
it inhibits the enzyme’s function (invertase and tranferase activity). Santos
and Maugeri (2007) conclude in their study that when comparing between a
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stirred tank reactor and a packed-bed reactor, they found to have no significant
difference with regard to the yield.
With the specific production method of β-D-fructofuranosidase using Pi-
chia pastoris as the host organism, the enzyme, when produced, is secreted
into the supernatant. This means that there will have to be a more intense
purification step to ensure that the enzyme is removed from the solution so
that the scFOS may be more pure. Another point is that the enzyme will be
wasted with the stirred tank reactor set-up because of the fact that it exits out
with the scFOS in solution. The packed-bed reactor has the enzyme packed
(which has been initially immobilised) and the sucrose flows through and the
FOS’s form without the enzymes leaving the reactor and thus being wasted.
This method is preferred as the enzymes remain in the reactor and therefore
a less intense purification step with the removal of the enzyme is not required
and thus less costly.
In Vaňková et al. (2008)’s design, a PBR was chosen as they chose to
immobilise their enzyme in the reactor and therefore have the enzyme in a
packed bed setup. The reactor type chosen for this project is an agitated
semi-batch reactor as the manner in which the enzyme was produced needed
this type of setup. The enzyme and the sucrose will flow into the reactor
simultaneously and reactor in the vessel to form the product.
The operating temperature is also another factor of importance as the
conditions need to be right for the optimal production of the FOS’s. The
reactor is chosen to be operated at 50◦C (Vaňková et al., 2008). Yang et al.
(2008), Yun and Song (1999) and Yun et al. (1994) suggested 55◦C, which
shows that the choice of operating temperature of 50◦C is reasonable.
The product that forms in the reactor has a 89% conversion of sucrose
(Vaňková et al., 2008). Sheu et al. (2002) and Yun and Song (1993) found to
have a sucrose conversion of 90%. The products that form are the following:
G, F, GF2, GF3, GF4, GF5, GF6 and GF7 as well as unreacted sucrose (GF).
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This means that 11% of the sucrose is unreacted. From this, Sangeetha et al.
(2004) says that of the 89% of the sucrose that has been converted, 58% forms
into FOS’s, 30% forms into glucose, 1% fructose and 11% sucrose. This split
does not account for the other smaller yields of the components of GF5, GF6
and GF7.
The assumption of the product splits for this design are: 65% FOS’s, 23%
glucose, 4% fructose, 4% sucrose, 2.5% GF5, 1% GF6 and 0.5% GF7. The
composition of the components that exit the reactor are shown in table 5.6.
Nishizawa et al. (2001) and Yun (1996) claim to have found a 55-60% yield of
FOS and Balken et al. (1991) also found to obtain a production yield of 60%.
2.2.4.2 scFOS Purification
There are a few different proposed methods for the purification of the fructoo-
ligosaccharides after they have been formed in the bio-reactor.
Vaňková et al. (2008) suggested the use of an SMB chromatography column
where they achieved a 95% separation. Vaňková and Polakovič (2012) also pro-
posed a method for FOS purification using SMB chromatography, where they
obtained a 95% yield of FOS’s. Vaňková and Polakovič (2010) investigated a
method for the optimisation of a single column chromatographic separation of
fructooligosaccharides and produced a yield of FOS’s of 86%. The reason for
this lower recovery is due to the fact that the single column has the one unit
compared to the design of Vaňková et al. (2008), where four chromatography
units in series were used. Nevertheless, 86% yield is still a good separation
with the use of only one column.
Nobre et al. (2011) and Kuhn and Filho (2010) found an efficient method
for fructooligosaccharide purification using a charcoal column adsorption tech-
nique where they obtained FOS recoveries of 97% and 97.8% respectively.
Nobre et al. (2011) made the technique sound very attractive by stating that
the method is a "simple and efficient way to purify FOS" and "it can be easily
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applied at a larger scale".
The downside however with the activated charcoal column is that ethanol,
which is a hazardous material, is used as an eluent for the column. This
means that extra process precautions would have to be put in place to ensure
that all hazardous risks are taken care of. SMB chromatography uses water,
which is a preferred option because of the non-hazard involved. Although the
charcoal column shows to have slightly higher recoveries compared to the SMB
chromatography column, the choice will still be to go with the chromatography
column because it does not use the potentially hazardous ethanol.
The SMB chromatography column purifies the reactor product through size
exclusion (Houwing et al., 2003). The true moving bed was developed before
the simulated moving bed and a schematic is shown in Figure 2.9.
Figure 2.9: A schematic diagram of a true moving bed chromatography column
(redrawn) (Bailly and Nicoud, 1993).
The contact between the solids and the eluent is counter-current. As shown
(Figure 2.9), the feed which consists of components A and B, are input into
the middle of the column. The assumption is that the attraction of A and
B for the solid differs and therefore as a consequence, the two components of
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A and B will separate. Component A should travel up the column, while B
drops down in the direction of the solid. B is the extract (desired) and A is the
raffinate (undesired). The counter-current systems have said to be preferred
because they have proven to be more effective than batch processes (Bailly
and Nicoud, 1993).
The downfall of the true moving bed process is that it its function cannot
be implemented correctly because the flow of the solids cannot be controlled
correctly. From this, the SMB technique was developed. This difference with
the SMB concept was that instead of moving the solid in a system that has
inlet and outlet lines at fixed positions, rather move the inlet and outlet in the
opposite direction of the desired solid flow (Bailly and Nicoud, 1993). Figure
2.10 shows the schematic setup of the simulated moving bed.
Figure 2.10: A schematic diagram of a simulated moving bed chromatography
column (redrawn) (Bailly and Nicoud, 1993).
The temperature for the operation of the chromatography column is also
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a parameter that needs to be determined. Vaňková et al. (2008) operates
their SMB column at 60◦C, while Vaňková and Polakovič (2012) also used
this operating temperature. Gramblička and Polakovič (2007) used a different
technique to purify their FOS’s, however they also used an operating temper-
ature of 60◦C to separate the sugars from the FOS’s. For the design of this
process the same temperature will be used.
2.2.4.3 scFOS Product Preparation
There has been work done on the applications of spray drying where processes
have found to use dry air operating at temperatures above 100◦C. A patent
by Mysore et al. (2004) suggested that for preparation of FOS’s, an inlet air
temperature of 130 to 140◦C is suitable and an outlet of 90 to 95◦C is expected.
Modler et al. (1993) used similar temperatures for the spray drying macerated
Jerusalem artichoke tubers (JAT) for producing JAT flour. Air temperatures
for the drying of FOS in this application were an inlet temperature of 200◦C
and an outlet air temperature of 95-102◦C. In another application of the spray
drying of Lactobacillus paracasei NFBC 338, Desmond et al. (2002) used a
constant air inlet temperature of 170◦C and the outlet temperature varied
between 95 and 105◦C. An industrial spray drying design application by Huang
and Mujumdar (2007) used inlet and outlet temperatures of 250 and 110◦C
respectively, with a product flow rate of 1200 kg/h. The corresponding co-
current air flow rate was 3.5-5.5 kg/s (12600-19800 kg/h).
From the experimental temperature values of the spray drying, the chosen
temperature would be an inlet of the hot dry air of 180◦C and an outlet
temperature of the water vapour that has been ‘caught’ by the hot dry air of
90◦C. The flow rate of the air would have to cater for an incoming product flow
rate of 2 691 kg/h (for a scFOS production rate of 10 000 tonnes per annum),
which suggests that the incoming air flow rate should be scaled up according
to the ratio of 2 691/1200, which equates to 37 878 kg/h of hot air (appendix
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E.2 shows sample calculations for hot air required for an scFOS production
scale of 2 000 tonnes per annum).
The evaporator was a unit operation that also needed to remove the mois-
ture from the by-product stream. The by-product stream exited the bottom
of the SMB chromatography column where most of the sugars of glucose,
fructose and sucrose were found as well as a fair amount of water. The evapor-
ator served its purpose to dry out the by product either for re-use or for sales.
The evaporator was chosen to be operated at 105◦C. This temperature choice
was influenced by the work of Pridgeon and Badger (1924) and Radović et al.
(1979).
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2.2.5 Process Hazards
In all process designs, the desire is to have a process that runs at optimal
conditions, producing the most product with the least costs. This is an aspect
that has good intentions but one must remember that the process must also
run in a safe manner, i.e. contain any possible hazards and also comply with
environmental regulations.
In the FFase production plant and subsequent scFOS production plant, it
must be reiterated that scFOS is for human consumption and therefore one
must ensure that the product is free of any components that could be harmful
to humans.
During the FFase production, the FFase is produced using P. pastoris with
either the GAPfopA gene or the AOXfopA gene. The AOXfopA gene uses
methanol as an inducer during the enzyme production. This enzyme is used
in scFOS production and thus poses a potential hazard in the process. It is
both a process hazard in that it is a flammable substance and it is harmful
to humans if consumed in quantities higher than 30 mg per day (USDHHS,
2012).
Environ© (2000) prepared a document for the GTC Nutrition Company
to state that scFOS has been given the ‘GRAS’ status. The GRAS report is a
large document that extensively researches scFOS to see whether it is safe for
human consumption. It is positive knowledge to know that Environ© (2000)
has given scFOS the status as generally recognised as safe.
According to the USDHHS (2012), in Table 2 of the document compiled by
their department of health and human services, methanol’s potential daily ex-
posure is 30 mg per day and the concentration limit for methanol is 3 000 ppm,
which is equivalent to 0.3%. In this process, it is mandatory to ensure that
in the final scFOS product, the methanol content is below these figures stated
above. The calculation shown in appendix E will show that the methanol
composition in the scFOS is within the allowable limit.
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2.2.6 Process Costing
2.2.6.1 Chemical Engineering Plant Cost Index
The production of FTase and FOS’s for annual production of 10 000 tonnes,
where as shown in the design (Figure 2.6), the production is separated into two
sections: a FTase production section, and a FOS production section (Vaňková
et al., 2008). Vaňková et al. (2008) has studied the costing of both the FTase
and the FOS production section and costed them separately, to determine how
much money is spent on the production of the separate processes.
Figure 2.11: The chemical engineering plant cost index. Figures from 1991-2006
obtained from Turton et al. (2008), figures from 2007-2010 obtained from Scribd
(2012) and the figure from 2011 was obtained from Cheresources (2012).
The list of equipment that was used for the FTase production process
(Table D.2) showed the description of the unit used (that corresponds to figure
2.6) as well as the cost of the equipment given in Euros. This paper was
written in 2008, so the figures would be adjusted according to the chemical
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engineering plant cost index (CEPCI). The CEPCI ensures that the historical
prices of equipment units will be up to date with the present time (see Figure
2.11).
The CEPCI is an index that is based, like inflation, on the increase in cost
with time. Turton et al. (2008) showed that the components of the CEPCI
index were broken up into four main categories, where the equipment, ma-
chinery, and supports comprised of 61% of the total weighting. The remaining
39% was made up of erection and installation labour, buildings, materials and
engineering of the plant.
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2.2.6.2 Costing Model
The costing of a production process is a task that has many components to
take into account. Capital cost is one of the first factors to consider as this
is the figure that possible investors would like to know when they have an
interest in a project. The capital cost also includes many other costs which
are based as a percentage of the equipment purchase cost. Potential investors
would also like to have a good idea of the operating costs. This involves all the
annual running costs, which includes raw materials, energy, utilities and labour
that will accrue during each year of operation. Table 2.5 and table 2.4 gives
a break-down of all the costs that are taken into account when performing a
costing analysis of a production plant.
To begin with, the costing analysis must begin with the land that is avail-
able. This has to be the first factor to take into account so that the factory has
a plot of land to be built on. The location of the land will be of much import-
ance as it will have an effect on the transport costs of buying raw materials
Table 2.4: Costing method adopted from Petrides (2000) used to calculate the fixed
capital cost estimation for the enzyme and scFOS production costs
COST ITEM Average multiplier Range of values
TOTAL PLANT DIRECT COST (TPDC)
1. Equipment Purchase Cost (PC)
2. Installation (0.50 * PC) 0.2 - 1.5
3. Process Piping (0.40 * PC) 0.3 - 0.6
4. Instrumentation (0.35 * PC) 0.2 - 0.6
5. Insulation (0.03 * PC) 0.01 - 0.05
6. Electrical (0.15 * PC) 0.1 - 0.2
7. Buildings (0.45 * PC) 0.1 - 2.0
8. Yard Improvement (0.15 * PC) 0.05 - 0.2
9. Auxiliary Facilities (0.50 * PC) 0.2 - 1.0
TOTAL PLANT INDIRECT COST (TPIC)
10. Engineering (0.25 * TPDC) 0.2 - 0.3
11. Construction (0.35 * TPDC) 0.3 - 0.4
TOTAL PLANT COST (TPC)
12. Contractor’s fee (0.05 * (TPDC + TPIC)) 0.03 - 0.08
13. Contingency (0.10 * (TPDC + TPIC)) 0.07 - 0.15
DIRECT FIXED CAPITAL (DFC) TPC = 12 + 13
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Table 2.5: Costing method adopted from Choi and Lee (1997) used to calculate
capital and operating costs for the enzyme and scFOS production costs
FIXED CAPITAL ESTIMATE SUMMARY Method
A. TOTAL PLANT DIRECT COST (TPDC) (physical cost)
a. Equipment Purchase Cost (PC) (PC)
b. Installation (summed over all units)
c. Process Piping (0.35 * PC)
d. Instrumentation (0.40 * PC)
e. Insulation (0.03 * PC)
f. Electrical (0.10 * PC)
g. Buildings (0.45 * PC)
h. Yard Improvement (0.15 * PC)
i. Auxiliary Facilities (0.40 * PC)
TOTAL
B. TOTAL PLANT INDIRECT COST (TPIC)
a. Engineering (0.25 * TPDC)
b. Construction (0.35 * TPDC)
TOTAL
C. OTHER COSTS (OTC)
a. Contractor’s fee (0.05 * (TPDC + TPIC))
b. Contingency (0.10 * (TPDC + TPIC))
TOTAL
D. DIRECT FIXED CAPITAL (DFC) (TPDC + TPIC + OTC)
ANNUAL OPERATING COST
A. DFC-DEPENDENT ITEMS
Depreciation
Maintenance Material (summed over all units)
Insurance (0.01 * DFC)
Local Taxes (0.02 * DFC)
Factory Expense (0.05 * DFC)
TOTAL
B. LABOUR-DEPENDENT ITEMS
a. Operating Labour (Working hours * rate * labourers)
b. Maintenance Labour (summed over all units)
c. Fringe benefits (0.40 * (a + b)
d. Supervision (0.20 * (a + b))
e. Operating supplies (0.10 * a)
f. Laboratory (0.15 * a)
TOTAL
C. ADMINISTRATION AND OVERHEAD EXPENSE (0.6 * (a + b + c)
D. RAW MATERIALS
E. OTHER CONSUMABLES
F. UTILITIES
G. WASTE TREATMENT/DISPOSAL
TOTAL ANNUAL OPERATING COST
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and sending out product. For the scFOS specifically, one would want to have
a plant that is close to a sugar mill so that the sucrose is in close proximity to
the scFOS plant.
Coincidently, in South Africa, sugar cane grows in the eastern parts of
the country where the climate is conducive for good sugar cane production
where in the summer months, there is a lot of heat and moisture. There also
happens to be two large harbours on SA’s east coast, namely Richards Bay
and Durban harbour (see Figure 2.12). Richards bay and Durban harbours
are areas that are close to large sugar mills and other industries. It would be
a convenient location for a proposed FFase and scFOS production plant, as
the scFOS would be produced close to the sugar mill where sucrose would be
readily available and the close proximity to the harbour. Also in these sugar
cane rich areas, there would be people that are experts in sugar production
and similar sucrose derived products (such as fructose). It would be sensible to
implement an scFOS production facility in an area such as this because there
would be people with the knowledge in this field who could potentially provide
expert knowledge in the field and make strong contributions to the success of
the business.
Figure 2.12: Different shipping routes around the globe (Redrawn). South Africa
has access to Europe along both the east and west coastlines of the continent of
Africa (Kumar, 2012).
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2.2.6.3 Engineering Economic Analysis
To decide whether a project will be viable or not, one needs to perform a
costing of the proposed project. It is very important to ensure that all costs
are taken into account so that the proposal is clear for possible investors to
look at and determine whether it will be advantageous to them for investment.
To give a better idea of the economic analysis of the production plant, a
cumulative cash flow diagram (see Figure 2.13) was set up to see the project
lifespan, where this will give possible investors the opportunity to have a good
idea if they would be interested in investing. The cash flow diagram shows
the initial cost of the land and the fixed capital investment and the working
capital costs. When the plant begins to operate, it will begin to pay back the
initial amount of money that was invested into the facility.
The information that will be of interest to the investors is the time when
the fixed capital investment is paid back otherwise known as the discounted
payback period (DPBP). Also, the break-even period would be of interest
and this is the time where the plant has paid back all its costs and starts to
make profit from its production process. The next figure that is needed, is a
projected value of the project at the end of its lifespan. The value must take
into account that the money will devalue in the future due to inflation so that
a true representation on the profits earned are shown. This figure is known
as the net present value (NPV) and is a very important figure to present to
investors.
The final figure that needs to be calculated for the cumulative cash flow
analysis is the internal rate of return (IRR). The IRR is the discount rate that
will cause the NPV to be equal to zero at the end of the project life. The IRR
is a figure that possible investors will look at and their decision to invest will
be strongly based on this figure.
The cash flow diagram corresponds to Table F.5, where the diagram is
explained in tabular format. This method was based on a technique used by
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Figure 2.13: A cumulative cash flow diagram when evaluating a new project (Re-
drawn) (Turton et al., 2008).
Turton et al. (2008) where the method of calculation is shown in Table F.5.
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2.2.7 Economies of Scale
In order for a production company to be successful, it needs to ensure that
it is sustainable and makes a good profit. To make a good profit, of course
one needs to produce a product that can be sold for a reasonable price while
keeping the costs as low as possible.
With regards to industrial enzymes and scFOS production, there are dif-
ferent scales of production that can be considered. This would be based on
the the amount of sugar that is available to be used in the scFOS production
process and also the scale would be based on the viability of the production
plant. There is no point designing a plant that is too large if it produces
product that is too much for the demand of the market. Vaňková et al. (2008)
proposed a design of a scFOS production rate of 10 000 tonnes per annum,
which corresponds to a sucrose input of approximately 17 000 tonnes per an-
num. The range of production scales that were considered were: 1 000, 2 000,
5 000, 10 000, 20 000, 30 000, 40 000, and 50 000 tonnes per annum of scFOS
production.
2.2.7.1 South African Sugar Production
An attractive aspect about the possibility of producing scFOS in South Africa
is that there is sucrose that is readily available. This means that the transport
costs will be much less when comparing with importing the raw material.
South Africa’s export sugar for the past 5 years is approximately 850 000
tonnes per year and their total production rate of sugar has been above two
million tonnes per year (except for 2011 because of bad droughts), see Figure
2.14 (SASA, 2012).
It is important to have the sugar information available for scFOS produc-
tion so planning can be done about production levels because the trends in
raw material production will show what to expect.
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Figure 2.14: South Africa’s Sugar Production (SASA, 2012)
2.2.7.2 Six tenths Rule
When costing a plant, one obviously needs to consider many costs that are
involved with the start-up and running of the plant. Costs can be broken
up into initial investment costs, fixed costs and running costs. This research
involves the subject of the costing of a large/industrial scale enzyme and scFOS
production facility. With regard to the initial investment or capital cost, the
six tenths rule linked with economies of scale is a topic of high interest. The
six tenths rule is given by equation 2.2.1, where the cost of equipment and
the increase in capacity of the unit of operation is related (Tribe and Alpine,
1986), (Turton et al., 2008).
CB = CA
(
AB
AA
)α
(2.2.1)
where A = equipment cost attribute
C = purchased cost
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α = cost exponent
Subscripts: A refers to the equipment with the required attribute
B refers to the equipment with the base attribute
Equation 2.2.1, shows the relationship between the cost attribute of the
equipment and the purchased cost, raised to the power of α. The six tenths
rule, as the rule suggests, assumes that the value of α is equal to 0.6. This
highlights an important concept of economies of scale and leads to the following
generalisation according to equation 2.2.1:
The larger the equipment, the lower the cost of equipment per unit
of capacity (Turton et al., 2008).
Fourie et al. (2008) backs this quote by saying that a firm will experience
economies of scale if the production scale increases. This is the reason that
there is an interest in the implementation of an industrial scale production
facility.
The influence of the six tenths rule is represented graphically (Figure 2.15).
It can be observed that as the cost attribute increases, the purchase cost will
also increase as expected, but when the six tenths rule is applied, it will not
increase as dramatically as the linear plot. Instead, the exponential line moves
further away from the linear plot as the cost attribute increases. The same
concept is illustrated in Figure 2.16.
This is why the scale up of a plant is attractive provided the product that
is produced in the facility will exceed the demand of the market.
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Figure 2.15: The representation of the effect the six tenths rule has on the cost of
equipment as it increases in size.
Figure 2.16: The cost per unit decreases as the output per time period increases
illustrating economies of scale (Fourie et al., 2008).
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2.2.8 ScFOS Markets
In order to be able to make money out of the proposed investment, the product
that is produced in this facility needs to be sold. Information about the various
markets is therefore very important and of very high interest.
ScFOS is a product that has recently become of interest in South Africa
following a joint venture project with Stellenbosch University and Rhodes Uni-
versity. The product of scFOS is already well established in east Asia, which
include countries such as Japan, South Korea, Taiwan and China. There is
also other interest for the product in Europe and North America.
Charalampopoulos and Rastall (2009) said that in 1995, the global market
for scFOS produced from sucrose was estimated to be 20 000 tonnes. They
stated further that the growth rate for oligosaccharides was 15% per annum.
If this was projected to present time the current scFOS global market demand
would be around 240 000 tonnes. Nakakuki (2002) said that the fructooligosac-
charide market was 6.5% of the global demand of prebiotics. The demand for
prebiotic oligosaccharides in Japan was found to be 69 000 tonnes per year
(Charalampopoulos and Rastall, 2009). It is important to remember that
fructooligosaccharides are considered to exist in the field of prebiotics and fur-
thermore, within the field of prebiotics, there is a group in oligosaccharides
where there are many other types of oligosaccharides such as mannan-, xylo-,
and galactooligosaccharides to name a few.
In a news article by 21tradenet (2010), it is stated that Japan’s leading
scFOS manufacturer, Meiji Seika Kaisha using their product ‘Meioligo’ found
that its market share was 3 000 tons in 2007. An article by Sinosweeteners
(2012) said that the development of functional oligosaccharides have opened
up many new industrial applications and in 2002, the global production of
oligosaccharides reached 150 000 tons. This created a US$40 billion functional
food market, a US$10 billion functional (animal) feed market. If this figure
of 150 000 tons was project with a CAGR of 15% and 6.5% of this value
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was assumed to be FOS’s, then the current FOS market would be 45 000
tons. Oligosaccharides also showed opportunities listed in drugs, pesticides
oligosaccharides and oligosaccharides fertilizer. After 1995, China’s functional
oligosaccharide began to produce oligosaccharides at an appreciable scale. The
products listed were maltose oligosaccharides, fructooligosaccharides, galactoo-
ligosaccharides, soybean oligosaccharide, stachyose and some others (Sino-
sweeteners, 2012).
A study done by Nakakuki (2002) determined the oligosaccharide demand
in Japan in 2002 (see Figure 2.17).
Figure 2.17: Japan’s oligosaccharide market demand based on a study done in
2002 (Nakakuki, 2002).
As it can be seen in Figure 2.17, the FOS in Japan contributes to 7% of the
total oligosaccharides which is 68 750 tonnes per annum (4 500 tonnes per year
of FOS). If this figure of 4 500 tons was projected to 2013 with a 15% CAGR,
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then the present FOS market in Japan would be 21 000 tonnes. Taniguchi
(2004) also did a study on the oligosaccharides production in Japan and found
information that is shown in Table 2.7. It can be seen that this information
correlates similarly to the figures given by Nakakuki (2002).
In an article by Watson (2011), they state that the United States prebiotic
market is forecast to double in the next five years to a figure of greater than
US$ 220 million. A research associate by the name of Tejaswini Prabhu said
that the prebiotic market in the United States is estimated at US$ 110 million.
Of this value, 35% is for inulin, 25% is for mannan oligosaccharides (MOS) and
10% is for fructan oligosaccharides (FOS). Therefore the FOS market would
be US$ 11 million and if the price of scFOS was taken to be US$ 10/kg, then
the FOS market would be 1.1 million kilograms or 1 100 tonnes.
GIA (2012) released a comprehensive report on the prebiotics market and
they predicted also that the United States market would reach US$ 225.31
million by 2015, which is close to the previous figure given of US$ 220, and
the European market would reach US$ 1.17 billion by 2015. If it was assumed
that scFOS is 6.5% of the total prebiotics market (Nakakuki, 2002), then the
US market would be US$ 14.3 million and the European market would be US$
76.1 million. If the price of scFOS was taken to be US$ 10/kg, then the US
market would be 1.43 millions kilograms or 1 430 tonnes and the European
market would work out to be 7 610 tonnes. Having looked at all figures given
the the respective sources, the global scFOS market could be assumed to be
approximately 50 000 tonnes.
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2.2.9 β-D-fructofuranosidase Market
2.2.9.1 FFase Markets and Freedom-to-Operate
With the production of FFase and the subsequent production of scFOS, there
is also an interest to know whether, in the dual production process of FFase
and scFOS, there is a market for FFase alone? If this happened to be the case,
FFase could be produced in excess so that the demand for scFOS production
is met, while still having FFase left over for extra sales. This would be ad-
vantageous since it allows for FFase production at a larger scale thus realising
lower production costs and improved returns on investment.
Before one can sell these products, one needs to know if it is allowed to
produce these product first of all. There are patents that exist regarding the
production of FFase as well as scFOS and one must be careful not to infringe
on any of these patents as this is illegal and could cause potential trouble.
The first issue was to distinguish whether FFase (FopA enzyme) can be
used for the production of scFOS and furthermore, can it be sold on the local
and international markets. The patents US6337201 by Yanai et al. (2008)
was examined and it was found that there are versions of this patent that
match and have been filed, and are being implemented in Japan, Taiwan, and
South Korea but no equivalent version has been granted in Europe and South
Africa. The patent US6337201 implies that the FopA enzyme produced by the
consortium cannot be sold in the USA, Japan, Taiwan or South Korea without
infringing on the aforementioned patent. 1
On the contrary, the consortium is allowed to commercialise the FopA
technology in two ways: i) FopA enzyme may be produced in South Africa
and exported to all countries in the world except for USA, Japan, Taiwan
or South Korea. ii) FopA that is produced in South Africa may be used to
1The consortium is the association involved in the scFOS project which consists of TIA,
University of Stellenbosch, and Rhodes University. TIA is a South African governmental
organisation that stands for Technology Innovation Agency. TIA strives to enhance techno-
logical innovation to improve economic growth and quality of life for all South Africans.
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produce scFOS in South Africa and the scFOS product produced can be sold
anywhere in the world.
From this information, it would be a good idea to know what the demand
for FFase is on a local and global scheme as this FFase and scFOS production
scheme could be able to sell scFOS and FFase together, which may increase
the incentive for possible investors.
It is known that there is an increasing global demand for scFOS, and con-
sequently, there is a need for FFase for scFOS production. Venkateshwar et al.
(2009) backs this up by saying that the development of this line of research
has become very significant and that the demand for FFase is increasing.
2.2.9.2 China Market Research Center
The China Market Research Center (CMRC), have compiled a market research
report on China’s β-D-fructofuranosidase only for scFOS Production. This re-
port entailed a detailed analysis of the global β-D-fructofuranosidase market
only for scFOS production which covered analyses such as operation and devel-
opment, market environment, market competition, import and export, leading
enterprises and development trend forecast (CMRC, 2012).
CMRC (2012) found that their country’s market demand for β-D-fructo-
furanosidase only for scFOS production has been increasing steadily over the
past three years. This would indicate that the market for scFOS is increasing
also. Royal DSM is a company that is internationally known to produce β-
D-fructofuranosidase as well as a large company that produces enzymes on an
industrial scale by the name of Novozymes®. The important fact to note is
that some countries manufacture β-D-fructofuranosidase, but it is not neces-
sarily used for scFOS production. In some cases the β-D-fructofuranosidase
is used to produce invert sugar and the β-D-fructofuranosidase is effectively
an invertase. Royal DSM actually produces a β-D-fructofuranosidase that
can only reduce sucrose to glucose and fructose (an invertase). Novozymes®
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produces a product called inulinase, which is an enzyme that breaks down
inulin to form the fructooligosaccharides. This product of inulinase would not
compete with β-D-fructofuranosidase for scFOS product as it performs a com-
pletely different function. Inulinase breaks down inulin to for scFOS, while
β-D-fructofuranosidase (specifically for scFOS production) builds up sucrose
to form scFOS. CMRC (2012) states that there is knowledge that there are
other companies in the USA, France, Japan, and others that produce β-D-
fructofuranosidase for scFOS production, but not on a large scale.
CMRC (2012) says that there is knowledge that other companies such as
the USA, France, Japan, and others that produce β-D-fructofuranosidase for
scFOS production, but not on a large scale. It was of recent knowledge that
China are developing a technology for FFase and scFOS production, which will
be implemented in a new manufacturing facility in China (Personal communic-
ation: Jorge Valdes Hernandez, Centro de Ingeniería Genética y Biotecnología
(CIGB), Havana, Cuba). According to CMRC (2012), there are few coun-
tries that produce β-D-fructofuranosidase on an advanced level and the main
areas are Holland, USA and Japan to name some important countries. It
is concluded that the international producers of β-D-fructofuranosidase are
relatively small, without strong market competition.
Everyone strives to improve their quality of life, and by doing so, this will
mean that people will strive for better health, which mean that products like
scFOS will have an increasing demand. If scFOS has an increasing demand; the
enzyme of β-D-fructofuranosidase will have an increase in its demand, therefore
the production and development of β-D-fructofuranosidase will definitely have
a promising future. The present situation in China is that they are importing
the β-D-fructofuranosidase but CMRC (2012) say that in the future, domestic
research will take place and the enzyme will be developed locally creating an
enzyme that should be available at a cheaper price and ultimately replace the
imported enzymes. China’s β-D-fructofuranosidase demand can be shown in
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Figure 2.18. As one can see, there is growth from 2008 and 2011, which shows
to be a promising trend for the future of the β-D-fructofuranosidase market.
Figure 2.18: China’s β-D-fructofuranosidase Market Demand Statistics from 2008
to 2011 (CMRC, 2012).
According to CMRC (2012), the import volume of β-D-fructofuranosidase
was greater than 10 000 tons in 2008. The imports decreased in 2009 and
stayed that way in 2010, but in 2011, the imports began to increase again
(see figure 2.19). The decrease in imports in 2009 and 2010 could be due
to increasing local β-D-fructofuranosidase manufacturing through domestic
research as stated previously. The slight rise in imports thereafter could be as
a result of increasing demand of scFOS as awareness of the product increases
and therefore increasing β-D-fructofuranosidase demand.
Regarding the export situation, the exports between 2008 and 2011 grew
every year, where there was good growth between 2009 and 2010, but from
2010 to 2011 the exports only grew by 141 tonnes (CMRC, 2012). The decrease
in exports could be due to local demand increasing which meant that not as
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much β-D-fructofuranosidase could be exported but rather used to meet local
demand. The export volumes reached 82 000 tons in 2011 (Figure 2.20).
Figure 2.19: Import volume of China’s β-D-fructofuranosidase products from 2008
to 2011 (CMRC, 2012).
Figure 2.20: Export volume of China’s β-D-fructofuranosidase products from 2008
to 2011 (CMRC, 2012).
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CMRC (2012) claim that at present, the total annual production of do-
mestic oligosaccharides (all types of oligosaccharides) amounts to approxim-
ately 100 000 tons, and the annual demand of oligosaccharides in China has
reached over 200 000 tons in 2011. As China is the most populated country in
the world, it would be of useful knowledge to observe their trend with regard to
their scFOS demand. East Asia would be a good indicator to follow to predict
trends around the globe for further β-D-fructofuranosidase and scFOS devel-
opment as countries in this part of globe have knowledge in scFOS production.
Japan does sell one of the stronger brands of scFOS known as Actilight® and
are therefore leaders in scFOS production (Vaňková et al., 2008). China is
also an influential East Asian country and the fact that they have a very large
population would suggest that they would be a significant player in the scFOS
market trends.
CMRC (2012) have forecasted their predicted market growth for the next
three years (Figure 2.21) and it can be seen in the graph that the demand is
predicted to grow at a steady rate every year until the year 2015. This will
take the demand to around 6.1 tons of β-D-fructofuranosidase for the year
2015.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 63
Figure 2.21: China’s β-D-fructofuranosidase demand forecasting from 2012 to 2015
(CMRC, 2012).
2.2.10 Environmental Impact
Environmental awareness is always a factor of concern in process engineering to
ensure that the implementation of the work does not disturb the surrounding
system. Falch (1991) show this by illustrating how the enzyme production
process, fits into an ecological loop.
Falch (1991) shows in Figure 2.22 that enzyme production can become part
of a sustainable ecological loop. The unused matter that is of no use to the
enzyme production plant, can be collected as a sludge and can then be spread
on a farmland so it may be processed and decomposed (Larsen et al., 1991).
The compositions of the sludge includes: dead biomass, filter aid, nutrient
surplus and insoluble debris (Falch, 1991).
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Figure 2.22: Enzyme production fitting into to an ecological cycle (Redrawn)
(Falch, 1991).
2.3 Common Recommendations and Problems
Short-chain fructooligosaccharides production and β-D-fructofuranosidase pro-
duction have been researched extensively for many years. The main challenge
that is at hand is to ensure that one produces the scFOS of a high quality
so that it is competitive in the international and national markets. In order
for this to be a success, one will need to look at the product that is presently
setting the standard. This product is Actilight® and it sets the standard of
the quality what the GF2, GF3 and GF4 ratios should be. To try and obtain
the best quality scFOS while keeping costs down, a good enzyme needs to be
produced.
The optimal conditions for the production of FFase are at a temperature
of 30◦C in the fermenter at a pH of 5.5 at atmospheric pressure. The agitation
and the carbon food source must be linked so that the organism has the right
sustenance and it can respire as needed so it can continue to grow and ferment
properly to ultimately produce the highest concentration of enzyme possible.
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To produce scFOS, a variety of enzymes can be used. The most popular
ones have shown to be fructosyltransferase and β-D-fructofuranosidase. This
research focuses on scFOS production using β-D-fructofuranosidase. When
considering the enzyme application for scFOS production, the enzyme must
experience conditions, where its activity is at a favourable level. The pH
in the bioreactor has shown to have an effect on the activity of the enzyme.
Hydrolase/invertase activity, which separates the sucrose molecule into glucose
and fructose, is favoured at pH 4 and transferase activity, which adds fructose
molecules to form longer chain fructooligosaccharides, is favoured at pH 6
(Fernández et al., 2004), (Katapodis et al., 2003). It is important to know
that glucose inhibits the enzyme, which decreases FOS production (Yun, 1996),
(Duan et al., 1994), (Jung et al., 1989). This is why it is important to ensure a
balance between the two enzyme activities. The best recommended conditions
for scFOS production are a reactor temperature of 60◦C and a pressure of 1
atmosphere and the pH must be around 5.5.
In terms of the equipment used for both the FFase and scFOS production
processes. The recommended equipment for the FFase production process
would be the standard procedure for enzyme production. It would consist
of a starter culture lab, followed by a fermenter. A centrifuge removes the
dead cells after fermentation and the broth is filtered further through nano-
filtration. The enzyme would then be kept in cold storage rooms to preserve
the enzyme.
Regarding recommended equipment for scFOS production; a CSTR would
be the preferred choice of reactor because the FFase exists in the supernatant.
Also, a CSTR can be run in the batch and semi-batch operation if need be. A
buffer tank needs to be present after the reactor to control flow into the SMB
chromatography column. The product from the column will then be prepared
for packaging through a spray dryer to remove all moisture. The by-product
is also treated by an evaporator to remove moisture for additional sales.
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Hypothesis and Key Questions
Presently in South Africa, there is no commercial industrial enzyme produc-
tion facility. The way companies have been getting around this problem is
by importing their desired enzymes from overseas for their various industrial
activities. Importing does not give any benefit to South Africa’s economy and
also to the companies that require enzymes. The companies would potentially
pay higher prices for products attained overseas because of issues such as trans-
port fees, import duties and exchange rates to name a few contributing factors
to higher costs. Regarding South Africa’s economy, producing enzymes locally
would hopefully offer a lower price and jobs would be created through the
construction, running and maintenance of the plant and business as a whole.
Another feature that is not desirable for companies that are obtaining their
enzymes from overseas lands, are that the companies would have to manage
their supply chain very carefully. If not, problems such as long arrival times or
over ordering of raw materials could occur. With this issue, the companies will
have to carefully plan their orders to ensure that they meet their local demand
while not having too much stock on hand, but at the same time, have enough
stock to be able to produce enough of their product for the local markets.
Another issue from the fact that the industrial enzymes are being bought
from overseas lands is that enzymes tend to lose their reactive activity if they
are left without being used for too long. The enzymes also need to be stored
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at low temperatures to preserve their activity level. To import enzymes would
require a transport unit that would have to transport the enzyme in a timeous
manner while maintaining the enzyme at a temperature of 4◦C, which could
turn out to be costly.
Some important questions in this research that need to be answered are:
• Is it feasible to create a facility that focuses and produces one enzyme
or does one create a multiproduct facility, where many different enzymes
are manufactured, be it commodity products, medium scale or high value
products?
• Is it feasible to create a facility that produces both FFase and scFOS
in the same facility or buy FFase from an external producer to produce
scFOS? And at what scales?
• Can an economic model be developed as a tool to determine if a multi-
product facility for industrial enzymes production in South Africa that
is an economically viable investment?
• What is the demand for these enzymes and how much does it cost to
manufacture the enzymes?
Hypothesis: FFase and scFOS production will be a viable economic ven-
ture provided the company can sell all of their product that they produce.
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Design Approach
4.1 β-D-fructofuranosidase and ScFOS Process
Outline
The core of the production facility is to produce enzymes on an industrial scale.
The enzymes will be produced throughout the year based on their demand.
FFase, as mentioned before is used in the production of the scFOS process,
therefore the demand of FFase will be based on the availability of sugar as well
as the market demand for scFOS.
When producing enzymes on an industrial scale, the culture first needs to
be developed in the laboratory. Organisms must be grown from the Petri dish
and developed further until they can become stable enough to be able to be
used as inoculum for large scale fermenters. Fermenter sizes are scaled accord-
ing to their demand for scFOS production. The organism grew in the first
fermenter until it reached a population where it needed to be transferred into
the final fermenter. The final fermenter was sterilised with high temperature
steam to ensure a sterile environment for the culture. The final fermenter
facilitates the actual fermentation process where the enzyme is produced.
The product from this fermenter was then sent to a large centrifuge where
98% of the cells were removed. The product was sent to storage where the
temperature was maintained at 4 degrees Celsius.
FFase was then taken to the scFOS production process, where the enzyme
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came into contact with the sucrose. FFase and sucrose were the main raw ma-
terials for the scFOS production process. The sucrose and the FFase were sent
into a continuously stirred tank reactor which operated at 60 degrees Celsius.
The scFOS was formed in the reactor and was then sent to a simulated moving
bed chromatography column, which purified the enzyme to a purity of approx-
imately 90 percent. The purified scFOS was then dried using a spray drier so
it can be in a powder form for sales. The by-product was also dried using an
evaporator and was sent for sales.
When implementing the costing of a proposed design, a plan of the project
needs to be set in place so that all aspects are covered and the project goes in
the direction as planned. Figure 4.1 gives an idea of the how the project was
planned.
Figure 4.1: Generic mind map of the process when designing and performing a
costing analysis of the implementation of a production facility.
As with all projects, one needs to come up with an initial idea or concept.
The initial idea for this project, which has been stated before, is the question
of the viability of the implementation of an enzyme production facility on
a commercial scale. Furthermore, the construction of an enzyme production
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facility in conjunction with an scFOS production process and the question of
viability of this process is also of interest.
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4.2 Process Description
In order to design the process of FFase and scFOS production, a detailed de-
scription of the process is needed, which will include details of exactly how the
process will be run. Details will include quantities of incoming and outgoing
streams of the process, as well as unit operations and an explanation of how
they will be run according to their operating parameters.
The production process of FFase and scFOS are mutually exclusive as the
scFOS production needs FFase as an enzyme and sucrose as the sugar to
produce the FOS’s. As a result, the processes needed to be operating in a
sequential set-up.
4.2.1 β-D-fructofuranosidase Production Process
4.2.1.1 Process Overview
In order for scFOS to be produced, the enzyme of β-D-fructofuranosidase
needed to be manufactured so that it can effectively perform its biochemical
reaction with sucrose in the scFOS process.
The strain of Pichia pastoris was genetically engineered by biochemists
to ensure that they employed an enzyme with the desired genes and that the
organism was able to express these genes when the enzyme was being produced.
In the proposed production facility, the yeast of P. pastoris will be grown
in Petri dishes in the preparation laboratory, where they will be grown to a
size that is sufficient for them to be transferred into fermenters. The yeast
will grow in the fermenters until it reaches a sufficient enough population for
actual fermentation to start. The fermenters are sterilised before the culture
enters the vessels. This is an imperative part of the process to ensure that the
production medium will not become contaminated when entering a new vessel.
The media is then sent to the final fermenter where the β-D-fructofuranosidase
is produced.
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The enzyme is secreted into the supernatant which means that the remain-
ing unwanted yeast cells will need to be removed from the enzyme ‘broth’. The
method to remove the unwanted cells is through centrifugation.
In any design project, one of the first steps in the design process is to
develop a block flow diagram. The block flow diagram will determine the
steps in the process that will convert the raw materials into the product. The
block flow diagram will also give a good idea what process unit will be suitable
for the respective steps in the production.
Before the process flow diagram can be drawn, an understanding of the
enzyme production process needs to be attained where a detailed knowledge
of the each unit operation must be known. Figure 4.2 shows a simple block
flow diagram, where the process steps are shown between the incoming raw
materials and the production of the enzyme.
Figure 4.2: Enzyme block flow diagram illustrating the concept behind the design
of the process.
4.2.1.2 Equipment Selection
When designing a production facility, the function of the process must be un-
derstood. There must be clarity in the goal of the process. A fair idea may be
in mind for the process flow diagram of the plant, but before this can happen,
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one must break the process down into steps and ensure that the correct piece of
equipment is chosen to satisfy the intended function of that step in the process.
Culture Preparation
To produce the enzyme, the culture needs to be prepared in a very careful
manner to ensure that the organism grows in an optimal manner without
contamination. The organism of Pichia pastoris was used as it is known that
P. pastoris can grow to very large biomass quantities. The organism is placed
initially in a Petri dish to be allowed to grow to a large enough population so
that it can be transferred into a test tube.
The P. pastoris, once transferred into the test tube is then treated with a
small amount of production medium. These are the nutrients needed for the
organism to grow and survive inside the test tube and allow for the population
to increase in size so that it can be moved to a larger vessel. Once the organism
has grown to a sufficiently sized population, the culture is then transferred to
a shake flask where it is treated with more production medium so that the
culture can grow further.
The culture will then be sent to a seed train of fermentation tanks (in-
creasing in size) where the culture will grow and will then be transferred to
the larger tank when necessary.
Fermentation
When the population of the yeast P. pastoris has reached its maximum and
the culture is in the final fermenter, the actual fermentation process begins.
The enzyme of β-D-fructofuranosidase is secreted from inside the yeast cells
out into the fermentation volume or into the supernatant. After fermentation,
the tank is left with the enzyme that exists in the supernatant and the dead
P. pastoris yeast cells at the bottom of the tank.
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Purification
Once the fermentation is complete, the dead yeast cells need to be removed
from the supernatant so that the enzyme can be stored for further use in other
processes. The dead yeast cells are removed through centrifugation and the
supernatant is sent through ultrafiltration to remove any extra impurities. The
protein now becomes more concentrated as the impurities are removed. The
dead yeast cells are removed from the process, and can be used in the ecolo-
gical loop for crop fertiliser.
Product Storage and Preparation
Once the enzyme has been produced; it is very important to store the enzyme
at the correct conditions to ensure that the enzyme does not degrade. If the
enzyme degrades then ultimately, it will ruin the quality of the short chain
fructooligosaccharides in the scFOS process. The enzyme, after purification,
needs to be stored at 4◦C. This is imperative for the performance of the en-
zyme when it is used in downstream processes so that the enzymatic activity
remains at its optimal value.
4.2.2 ScFOS Production Process
4.2.2.1 Process Overview
The scFOS production process follows a generic process pattern but the benefit
is that the raw materials coming into the process do not need to be pre-handled,
but only diluted. The block flow diagram is shown in Figure 4.3. The sucrose
will arrive in bags where they will be mixed with hot water to bring the
concentration down to the correct reaction specification. The FFase and the
sucrose are sent straight to the bioreactor where the reaction can take place.
There is a buffer tank that is placed after the reactor, to provide a flow control
between the reactor and the SMB chromatography column.
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The purification step concentrates the product to a higher level, after which
the product is then prepared for selling. The by-product, which also has its
uses is also sold to a willing buyer in the sugar industry.
Figure 4.3: ScFOS block flow diagram illustrating the concept behind the design
of the process.
4.2.2.2 Equipment Selection
Reactor
There were two different types of reactors that were considered for the oper-
ation of the scFOS process. The first reactor setup is a packed bed reactor
(PBR). With this type of reactor, the enzyme needs to be fixed in a bed and
the sucrose would flow through the fixed enzymes and react to form the scFOS.
The challenge with this reactor setup is issue of immobilising the enzyme.
β-D-fructofuranosidase can be produced in numerous ways using different
organisms and production techniques. Also, depending on the production
method, the enzyme can be produced within the cells of the organism or the
enzyme can be secreted in the supernatant. If the PBR reactor setup is chosen,
the enzyme would have to be produced in a way that is conducive for the
enzyme to be immobilised.
The other way to produce the scFOS is in a continuously stirred tank
reactor (CSTR). In this method, the enzyme and the sucrose enter the reactor
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in separate streams, where they mix in the vessel and the reaction is allowed
to take place. Using the CSTR, the enzyme can exist in the supernatant and
flow into the reactor in a liquid form and mix with the sucrose to form the
scFOS.
The CSTR reactor setup has been chosen because a very good method to
produce β-D-fructofuranosidase has been found, where the organism of Pichia
pastoris is used as the host for the enzyme production. Very good yields of en-
zyme are obtained by using P. pastoris and by using this method, the enzyme
is secreted into the supernatant, which means that the CSTR reactor would
be more suitable for the scFOS production.
Storage
Before the scFOS can be sent for purification, there needs to be a buffer tank
between the two process steps so that there is control and time between the
production of scFOS and the purification of the product. This is an important
step of the process as it will allow time for the reaction mixture to settle and
stabilise before it it sent to the SMB column.
Purification
The scFOS, before it is sold, needs to be sent to a purification unit to bring
the purity up to a level of 95% or above. The impure scFOS leaves the buffer
tank. There are two well known techniques that are used for the purifica-
tion of the scFOS and they are simulated moving bed chromatography and
activated charcoal column. They are both very effective techniques to remove
the unwanted sugars (fructose, glucose and sucrose) from the process, both
achieving purification rates of 95% or above. A factor that may deter the use
of the charcoal column is the fact that it uses the potentially risky chemical of
ethanol as an eluent in the process. SMB chromatography simply uses water
as the eluent in the process.
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The choice would be to use the simulated moving bed chromatography
technique as it is a well recognised method that is known to be used a lot in
literature and it is also known to be used by local sugar producers in South
Africa for fructose production. The technique has no hazardous materials and
achieves a good separation, which are the influencing factors that will favour
the choice of this technology.
Product Preparation
ScFOS is known to be sold in two different forms; in the syrup form and in
the powder form. Depending on what the industry demands will determine in
which form the product will be sold. The good news is that the process can
cater for customers that request scFOS both in the powder and syrup form.
To prepare the dry scFOS in powder form, the ‘wet’ scFOS that exits the SMB
chromatography column is sent to a spray dryer. The spray dryer works in a
way that is shown in Figure 4.4. The stream enters the hot drying chamber
through a nozzle. The nozzle essentially sprays the entering ‘wet’ stream of
scFOS into the hot chamber and the moisture is then absorbed by the hot dry
air.
The dried product exits out the bottom of the chamber and is sent to
packaging, while the cooled air exits out the side of the chamber and is sent to
a cyclone where it is cleaned. The dry product is also filtered once more and
the unwanted air is also sent to the cyclone where it is ultimately sent to the
exhaust.
By-product Handling
From the SMB chromatography column, comes the by product which consists
mainly of glucose, fructose, and sucrose. This stream can also be sold as there
are still useful sugars in this stream. This stream, like the product stream
from the SMB chromatography column also needs to be dried as it contains
moisture that is undesirable. The piece of equipment that is used to treat
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Figure 4.4: Schematic diagram of the setup and operation of a spray dryer (Re-
drawn) (Patel et al., 2009).
the by-product is an evaporator. The stream will simply enter the evaporator
and be subjected to high temperatures. As the temperature of the stream
increases, the moisture will evaporate out and the by-product will become dry
and be ready for selling.
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4.3 Process Designs
4.3.1 β-D-fructofuranosidase Production Process
The raw materials needed are the host organism (P. pastoris) with the impreg-
nated gene (AOX). The organism is grown in Petri dishes, and then transferred
into the shake flask. The production medium, which will allow for healthy
growth in the shake flask is the next step of the enzyme production process.
Sterilisation of the fermentation vessels, is a very important part of the
process. If the culture becomes contaminated, it would be a very big waste of
time and money in the enzyme production process and it must be avoided at all
costs. The fermentation vessels will be treated with cleaning in place systems
using spray balls and caustic soda solutions. The final fermenter will also be
treated with high pressure steam to ensure that there is absolute sterility in
the fermenter.
The fermentation will begin once the culture has developed and begins to
feed on the carbon source while receiving oxygen. The β-D-fructofuranosidase
is produced within the cell and is then secreted into the supernatant. The su-
pernatant is basically the entire liquid broth that includes all the ingredients
needed for the fermentation to occur. The broth also includes other proteins
that may have formed during the fermentation, but these are undesired. Only
the pure β-D-fructofuranosidase is desirable, which means that the other con-
stituents need to be removed.
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To purify the enzyme, the dead yeast cells need to be removed from the
fermentation broth. This is done by centrifugation. The centrifuge will remove
almost all of the cells but there will still be metabolites and other proteins
that will form during the fermentation that need to be removed. These other
components that form can be removed via ultrafiltration.
Once the block flow diagram was drawn, the actual process flow diagram
could be constructed specifying the respective unit operations that need to be
put in place to ensure that the process was designed correctly. The process
flow diagram is shown in Figure 4.5 and can clearly show all the raw materials
that are needed for the process, stream numbers and an explanation of the
unit operations used in the process.
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Figure 4.5: Production process of β-D-fructofuranosidase.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 4. DESIGN APPROACH 82
4.3.2 ScFOS Production Process
The process flow diagram of the scFOS production process (Figure 4.6) is
developed from the block diagram, where the unit operations and the choice
of the equipment is combined to form a concise diagram with numbered flow
streams and numbered equipment pieces.
The scFOS production process needs raw sucrose from a sugar production
mill along with the enzyme β-D-fructofuranosidase. The enzyme which is pro-
duced in a separate enzyme production facility will be sent into the bioreactor
along with the sucrose that would be shipped in from a mill. The pH and
temperature are maintained at the desired level so that the biochemical reac-
tion was allowed to take place. The typical conversion of the sucrose to scFOS
is 60% so when the scFOS is produced in the reactor, there is still unreacted
sucrose as well as remaining fructose and glucose, which needs to be removed
to form a purer product.
The product from the bioreactor is then sent to a purification unit, which
uses a simulated moving bed chromatography technique. This unit typically
achieves a 95% purification rate and will remove the fructose, glucose and
unreacted sucrose from the mixture, leaving a pure scFOS in syrup form. The
raffinate from the SMB chromatography column is also treated further.
The scFOS is then sent to a spray drying unit where the moisture is removed
from the scFOS that was in syrup form. The scFOS in powder form is then
ready to be sold. The raffinate from the SMB column is also treated with
an evaporator, where the moisture is also removed and the by product, which
consisted mainly of fructose, glucose and sucrose is also sold. Heat exchangers
are implemented to save any energy that would be lost in the process.
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Figure 4.6: ScFOS production process
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4.4 Process Scheduling
In order for an enzyme production facility to be able to run properly, it needs
to have a scheduled process to be able to operate in a orderly manner and
optimise production. Not only is it important for production, but it is also
important to have a schedule so that the equipment can be cleaned on a regular
basis. This will ensure that the risk of contamination is reduced so that the
culture will grow at an optimal rate.
During a run, the culture will be developed in labs and the culture would
then be transferred into a seed train of fermentation vessels. These vessels
before hand are washed with a cleaning-in-place system using spray balls and
caustic soda solution. The final fermenter in the seed train is cleaned with
high pressure steam to ensure absolute sterility.
The schedule is shown in Figure 4.7 where it can be seen that the facility
can cater for a possible 4 strains/lines of enzyme production.
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Figure 4.7: Production schedule of the multi-enzyme production facility. FFase
production schedule is to satisfy the needs of a continuous production process of
scFOS.
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Mass and Energy Balance
The mass and energy balance forms the fundamental part of chemical engin-
eering process design. It is essential to know exactly what is happening in
the process with regards to the flow rates, pressures, and temperatures of the
stream in the process. It is also important to know the specifications of the
unit and to know all the information regarding the units. This will include
sizing, operating conditions and stream composition entering and exiting the
unit.
In this project, the enzyme production process and the scFOS production
process are linked to one another in the way that the scFOS production levels
will determine the amount of FFase that is needed for the scale and the FFase
production process will be designed accordingly.
5.1 Mass Balance
5.1.1 FFase Production Process
5.1.1.1 Laboratory Operations
FFase production uses a fed batch fermentation process to produce the enzyme,
but before one can put the ingredients into the reactor, preparation of the
inoculum and production medium needs to be done.
The method that was used to produce the enzyme was practised by the
University of Stellenbosch in small scale biological laboratories. However, this
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technique needed to be adjusted and adapted to industrial scale, where many of
the more expensive ingredients where replaced with effective cheaper ingredi-
ents that are more feasible for industrial enzymes production. The benefit
is that with industrial enzymes production, the product does not have to be
entirely pure because the enzymes are produced on such a large scale. But at
the same time, every effort must be made to ensure the product is as pure as
possible.
The inoculation of the culture in the industrial enzyme production process
will begin in a laboratory environment. The inoculation occurred in two stages.
Initially, a 4 ml sample, which has the composition shown in Table 5.1, was
prepared in a test tube (see V-101 in Figure 4.5). The ingredients were put
into the test tube with one to three colonies of P. pastoris from the yeast
peptone dextrose (YPD) agar plate. The organism was left to grow in the test
tube for 16-24 hours at 30◦C on a test tube spinning wheel.
Table 5.1: Pre-inoculum used for the production of FFase
Pre-inoculum Operation
2.76 ml dH2O Autoclave
0.4 ml 1M Phosphate buffer, pH 6.0
0.4 ml 10x Yeast nitrogen base (YNB) Filter sterilise
8 µl 500x Biotin
0.4 ml 10% Glycerol
The second stage inoculum involved a volume of 40 ml, where the pre-
paration amount was tenfold the amount inoculated in the seed inoculum (see
Table 5.2). The medium was prepared in a 250 ml shake flask (V-102 in Figure
4.5), and included in the 40 ml solution was the seed inoculum prepared in
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the shake flask. The shake flask was incubated at 30◦C and 200 rpm overnight
(16-24 hours).
Table 5.2: Second stage inoculum used for the production of FFase
Pre-inoculum Operation
27.6 ml dH2O Autoclave
4 ml 1M Phosphate buffer, pH 6.0
4 ml 10x Yeast nitrogen base (YNB) Filter sterilise
80 µl 500x Biotin
4 ml 10% Glycerol
5.1.1.2 Reactor Setup (using GAP Production Strain)
From the shake flask, the grown culture was sent to the fermenter (R-101 from
Figure 4.5), where more additions were added to the reaction mixture to ensure
that the enzyme production occurred as desired. The components that were
put into the reactor was shown in Table 5.3, which is the industrial medium
for FFase production using the GAP production strain.
In the reactor, the temperature is maintained at 30◦C (Yun and Song, 1999)
using a glycerol coolant, that does not form part of the mass balance. There
is compressed air that is supplied to the system in order for the organism to
respire, and it exits the compressor (C-101 from Figure 4.5) at a pressure of
0.4 bar and enters the bioreactor at a flow rate of 1 vvm (volume of gas per
volume of medium per minute). The air is supplied when needed, according to
how the organism is using its glycerol food source. The agitation is also linked
to the the dissolved oxygen concentration to ensure the air that is supplied is
dissolved in the medium (dissolved oxygen concentration is maintained above
30% air saturation). The agitation speed is cascaded from 200-1000 rpm. The
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pH of the medium was at pH 5, but the solution can deviate up to a pH of
5.5. A 25% solution of ammonium hydroxide was used to control the pH (Yun
and Song, 1999).
The glycerol batch phase started when the 360 ml production medium
(Table 5.3) was inoculated with the 40 ml inoculum that was prepared in
the shake flask. The glycerol batch phase lasted for 24-27 hours and during
this phase the aeration rate was increased with a decrease in agitation. A
cell concentration of 90-150 grams of wet cells per working volume should be
attained before the glycerol fed batch phase can proceed.
For the glycerol fed batch phase; 50% glycerol (stream 6 in Figure 4.5) was
added by a constant feed at 18.15 ml/h/L of initial fermenter volume. The
glycerol feed was controlled by virtue of the dissolved oxygen content, where
if the dissolved oxygen rose above 30%, then the glycerol is fed, but when the
dissolved oxygen drops below 30%, the glycerol feed is stopped.
Table 5.3: Industrial medium components used for the production of FFase using
the GAP production strain
Industrial medium Concentration 1L reactor Mass Density Volume
(g/L) (g) (%) (g/ml) (ml)
Glycerol (batch) 40.0 404.2 41.7% 1.26 400.0
Glycerol (fed batch) 700.0 473.1 48.9% 1.26 400.0
Yeast extract 10.0 8.0 1.0% 1.20 6.7
Phosphoric acid 85% 56.3 45.0 4.7% 1.69 26.7
Calcium sulphate 1.2 0.9 0.1% 2.32 0.4
Potassium sulphate 22.8 18.2 1.9% 2.66 6.8
Magnesium sulphate-7H2O 18.6 14.9 1.5% 2.66 5.6
Potassium hydroxide 5.2 4.1 0.6% 2.04 2.0
TOTAL 968.4 100.0% 848.2
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5.1.1.3 Reactor Setup (using AOX Production Strain)
The experimental set-up when using alcohol oxidase (AOX) as a promoter is
the same as when using GAP, except with AOX, the gene has to be induced
with methanol. The reactor set-up procedure follows the same method as
GAP until the glycerol fed batch phase. The glycerol fed-batch phase stops
when the wet cell concentration reaches 180-220 grams per litre. The meth-
anol fed batch phase is then introduced, where 100% methanol (stream 7 in
Figure 4.5) is added. The methanol is fed initially at 1.8 ml/h/L of the initial
fermenter volume for one hour. The feed rate is then increased incrementally
to 3.6, 5.4, 7.3, 9.1 and 10.9 ml/h/L. The feed rate at 3.6 and 7.3 ml/h/L
was fed for two hours and the feed rate at 5.4 and 9.1 ml/h/L lasted for one
hour. At the end, 10.9 ml/h/L was kept for the remainder of the fermentation.
Table 5.4: Industrial medium components used for the production of FFase using
the AOX production strain
Industrial medium Concentration 1L reactor Mass Density Volume
(g/L) (g) (%) (g/ml) (ml)
Glycerol (batch) 40.0 404.2 47.9% 1.26 400.0
Glycerol (fed batch) 400.0 110.4 13.1% 1.26 100.0
Methanol (fed batch) 1000.0 237.5 28.2% 0.79 300.0
Yeast extract 10.0 8.0 1.0% 1.20 6.7
Phosphoric acid 85% 56.2 45.0 5.3% 1.69 26.7
Calcium sulphate 1.2 0.9 0.1% 2.32 0.4
Potassium sulphate 22.8 18.2 2.2% 2.66 6.8
Magnesium sulphate-7H2O 18.6 14.9 1.8% 2.66 5.6
Potassium hydroxide 5.2 4.1 0.5% 2.04 2.0
TOTAL 843.3 100.0% 848.2
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5.1.1.4 Downstream Operations
The enzyme is slowly produced and secreted into the supernatant during fer-
mentation. The FFase exists in the enzyme broth - it is an extracellular enzyme
product. The components that exit the reactor are: carbon dioxide from the
respiration of the organism, oxygen which has not been used by the organism,
nitrogen which forms part of the air make up of the aeration during the fer-
mentation. The main and most important component that exits the fermenter
is the fermentation broth. This broth contains the β-D-fructofuranosidase as
well as other proteins and metabolites and the dead P. pastoris cells.
The medium is sent to a centrifuge (F-101 in Figure 4.5), where approxim-
ately 98% of the dead P. pastoris cells are removed from the product medium.
The medium is finally sent to a 22µm ultra-filtration unit (F-102 in Figure 4.5)
to remove any unwanted proteins, metabolites and the rest of the P. pastoris
cells. The enzymes are then sent to a refrigeration unit (V-103 in figure 4.5)
to be stored.
Table 5.5 shows the material stream table of all the component flows and
their mass percentages of all the important streams in the process. This stream
table is based on the process flow diagram shown in Figure 4.5 and also the
enzyme production levels that will be able to supply to a scFOS production
facility that produces 2 000 tonnes per annum of scFOS.
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5.1.2 ScFOS Production Process Description
5.1.2.1 Reactor Feed
The scFOS production process receives the enzyme β-D-fructofuranosidase
along with sucrose which is fed at a flow rate of 421 kg/h into a semi-batch
reactor with agitation (R-102 in Figure 4.6). The scFOS production rate of
2 000 tonnes per year, which equates to 253 kg/h. The sucrose enters at a
concentration of 600 kg/m3 and at a volumetric flow rate of 0.7 m3/h. A re-
cycled water stream from the from the FOS purification step joins the sucrose
solution and this combined stream enters the semi-batch reactor.
5.1.2.2 Reactor Set-up
A semi-batch agitated reactor was chosen for the reactor setup of the scFOS
production process. Both the enzyme and sucrose enter the semi-batch reactor
at an enzyme flow rate of 0.0043 gram of average AOX fermentation broth per
gram of sucrose. This effectively works out to be a incoming flow rate of
1.8 kg/h. The components will enter the reactor and be heated up to the
designated temperature of 60◦C and be held for the specified reaction time of
4 hours until the desired amount of kestose, nystose and 1F -fructofuranosyl
nystose is formed. The desired composition will be aimed at the composition
of Actilight®, which is 35-40% GF2, 50-55% GF3 and 5-10% GF4. The scFOS
mixture will exit out of the reactor after the specified reaction time. The
mixture will contain primarily the scFOS’s as well as the unreacted sugars and
some of the enzyme (see Table 5.6).
The calculated yield for the FOS’s of this experiment is found to be 60%,
which shows to be very similar to the yields found in literature. The FOS’s
that are produced from the reaction of the sucrose with the enzyme are sent to
a blending/storage tank V-104 via stream 4 in the scFOS process flow diagram
(Figure 4.6).
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Table 5.6: Reactor product (FOS in syrup form before purification)
Component Flow rate (kg/h) Mass % Mass % (excluding water)
Kestose (GF2) 94.10 12.74 23.10
Nystose (GF3) 125.56 16.98 30.81
1F -F-Nystose (GF4) 23.54 3.18 5.78
GF5 9.36 1.27 2.30
GF6 3.74 0.51 0.92
GF7 1.87 0.25 0.46
Fructose (F) 14.97 2.02 3.67
Glucose (G) 86.08 11.64 21.12
Sucrose (GF) 46.52 6.28 11.40
FFase 1.82 0.25 0.45
5.1.2.3 scFOS Purification
The scFOS that leaves the reactor needs to be purified to a high FOS per-
centage from 60% to 95%. The fructose, glucose and sucrose are extracted
from the solution to give a FOS-rich product. The purification step is done
via simulated moving bed (SMB) chromatography and is shown by the unit
R-103 in Figure 4.6.
The design specified the SMB chromatography column to operate at 60◦C
to ensure a 95% FOS recovery. The extract (Table 5.7) from the column was
then sent to a spray drying unit, F-104 (Figure 4.6), where the water was
removed from stream 5. The raffinate (Table 5.8), which contained 95% of
the mono and disaccharide sugars, exited out of the bottom of the column via
stream 8 and entered an evaporation unit, E-101 (Figure 4.6).
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Table 5.7: SMB column product (FOS in syrup form before product preparation)
Component Flow rate (kg/h) Mass %
Kestose (GF2) 89.40 15.75
Nystose (GF3) 119.20 21.00
1-F-Nystose (GF4) 22.35 3.94
GF5 8.88 1.56
GF6 3.55 0.63
GF7 1.78 0.31
Fructose (F) 0.75 0.13
Glucose (G) 4.30 0.76
Sucrose (GF) 2.32 0.41
Water 315.06 55.51
Total 567.58 100
Table 5.8: SMB column raffinate (FOS in syrup form before product preparation)
Component Flow rate (kg/h) Mass %
Kestose (GF2) 4.71 2.75
Nystose (GF3) 6.27 3.66
1-F-Nystose (GF4) 1.18 0.69
GF5 0.47 0.27
GF6 0.19 0.11
GF7 0.09 0.05
Fructose (F) 14.21 8.29
Glucose (G) 81.72 47.69
Sucrose (GF) 44.10 25.74
Water 16.58 9.67
FFase 1.82 1.06
Total 171.34 100
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5.1.2.4 scFOS Product Preparation
The scFOS then entered the production preparation section of the scFOS pro-
duction process. A spray dryer was used and the inlet temperature of the
hot dry air was 180◦C. The outlet temperature of the water vapour that has
been ‘caught’ by the hot dry air was 90◦C. The flow rate of the air would
have to cater for an incoming product flow rate of 568 kg/h (see Table 5.7,
which suggests that the incoming air flow rate should be 7 563 kg/h of hot air
(spray dryer specification were influenced by the work of Huang and Mujumdar
(2007), see Appendix E section E.2 for sample calculations).
Table 5.9: Dry scFOS product for selling
Component Flow rate (kg/h) Mass %
Kestose (GF2) 89.46 35.40
Nystose (GF3) 119.28 47.20
1-F-Nystose (GF4) 22.36 8.85
GF5 8.89 3.52
GF6 3.56 1.41
GF7 1.78 0.70
Fructose (F) 0.75 0.30
Glucose (G) 4.30 1.70
Sucrose (GF) 2.33 0.92
Total 252.71 100
The evaporator was a unit operation that also needed to remove the mois-
ture from the by-product stream. The by-product stream exited the bottom of
the SMB chromatography column where most of the sugars (glucose, fructose
and sucrose) were found as well as a fair amount of water. The evaporator
served its purpose to dry out the by product either for re-use or for sales. The
evaporator operated at 105◦C. Table 5.9 shows the dried scFOS that will be
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Table 5.10: Dry by-product for selling
Component Flow rate (kg/h) Mass %
Kestose (GF2) 4.47 3.08
Nystose (GF3) 5.96 4.10
1-F-Nystose (GF4) 1.12 0.77
GF5 0.44 0.31
GF6 0.18 0.12
GF7 0.09 0.06
Fructose (F) 13.51 9.30
Glucose (G) 77.69 53.41
Sucrose (GF) 41.99 28.87
Total 145.45 100
suitable for sales, where again the water was removed and it was assumed that
95% of the carbohydrates were separated and the dry by-products were sent
for selling (see Table 5.10).
The entire stream table that corresponds to the process flow diagram in
Figure 4.6 is shown in Table 5.11. The mass balance focuses on the production
scale of 2 000 tonnes per annum, which is the scale of interest in this project.
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5.2 Energy Balance
5.2.1 Enzyme Production Process
There were five main sections that were looked at for the energy balance around
the FFase production process: i) the energy used for the high pressure steam
sterilisation of the fermenters for each new batch, ii) the energy used for the
continuous agitation in the vessel during fermentation, iii) the energy used to
control the temperature of the fermenter at 30◦C, iv) the energy used for the
centrifugation step of the process when removing all the dead cells from the
enzyme broth, and v) the energy used for the continuous cold room storage to
ensure the enzymes maintain their level of activity.
5.2.1.1 Sterilisation
High pressure steam sterilisation is imperative for any biological process. Due
to the nature of biology, there are so many organisms in the environment,
it is important to keep the system sterile. The sterilisation conditions were
high temperature short time (HTST), which were 141 ◦C and at a time in the
fermenter for 10 seconds before the batch process. The energy calculation was
calculated on the energy required to heat the inner walls of the fermenter to
141 ◦C. The necessary information was obtained and the calculation is shown
in Table 5.12.
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Table 5.12: Energy used for the high pressure steam sterilisation of the fermenter
in the FFase production process, producing 14.43 tonnes per annum using the AOX
production strain
Item Amount Unit
Cpwater 4.186 kJ/kg.K
ρwater 1 000 kg/m3
Fermenter volume : boiler volume (Already Enterprises, 2013) 72 : 3 L
Vfermenter 0.620 m3
Vboiler 0.026 m3
∆Hv (Marsh, 1987) 2 233.901 kJ/kg
T1 141 ◦C
T2 25 ◦C
E = ρ.Vboiler.Cpwater.dT(100−25)+ρ.Vboiler.∆Hv 12 683.057 kJ
+ρ.Vboiler.Cpwater.dT(141−100)
Steaming time 10 seconds
Power (P) 1 268.306 kW
Fermentations per year 26 times
Energy for a year = 26*10s/3600*P kW.h
Energy for a year 91.600 kW.h
Cp = specific heat, ρ = density, V = volume, T = temperature, dT = change in temperature, E =
energy
5.2.1.2 Aeration
In order for the organism to be able to grow well, the organism needs the
correct food source as well as to be able to respire. The fermenter is supplied
with compressed air. Table 5.13 shows the energy required for the compressor
to deliver the compressed air to the fermenter.
The agitation is important to allow the yeast to grow in the system so that
when the enzyme is produced, its concentrations will be maximum. Regard-
ing the energy consumed during the agitation of the process, Turton et al.
(2008) proposed an energy correlation relating the energy consumptions and
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Table 5.13: Energy used for aeration in the fermenter for the FFase production
process producing 14.43 tonnes per annum using the AOX production strain
Component Amount (Unit)
Air flow rate 0.012 kg/s
Enthalpy (0.400 bar) 301.370 kJ/kg
Enthalpy (1.013 bar) 600.712 kJ/kg
Energy E = m(h2-h1) kW
Energy 3.661 kW
Energy for a year 28 995.112 kW.h
the volume of the vessel. Table 5.14 shows the method of calculating the an-
nual energy consumption for the agitation during fermentation when producing
FFase.
Table 5.14: Energy used for the agitation in the fermenter for the FFase production
process producing 14.43 tonnes per annum using the AOX production strain
Item Amount Unit
Energy (Turton et al., 2008) 0.3 kW/m3
Fermenter volume 0.561 m3
Hours in a year (330*24) = 7 920 h
Energy for a year 1332.400 kW.h
5.2.1.3 Temperature Control
Another important part of the fermentation is temperature control. The or-
ganism is very sensitive to the temperature it exits in and one can optimise
its growth if it is subjected to a temperature that will be favourable to its de-
velopment. According to Shay et al. (1987), the organism generates metabolic
heat when it is growing and therefore the temperature in the fermenter will
need to be controlled to ensure the best growing conditions. The correlation
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that Shay et al. (1987) used was 109 kcal/L/h of heat generated when the
dissolved oxygen levels were between 20-25%. For this project the dissolved
oxygen levels were specified to be at 30% and the correlation had to be ad-
justed accordingly. The rest of the information was known and the energy
calculation method can be seen in Table 5.15.
Table 5.15: Energy used for the temperature control in the fermenter for the FFase
production process producing 14.43 tonnes per annum using the AOX production
strain
Item Amount Unit
Metabolic heat generation (22.5% dO2) 109 kcal/L/h
From Shay et al. (1987) = 456.36 kJ/L/h
dO2 in Shay et al. (1987) 20 - 25 %
dO2 in experiments 30 %
Metabolic heat generation (30% dO2) 145.33 kcal/L/h
= 608.48 kJ/L/h
E V.E’.t kW.h
V 560.77 L
E’ 608.48 kJ/L/h
t 330*24 hours
P = V.E’ 94.78 kW
E P.t kW.h
COP (New Buildings Institute, 1998) 4
Energy for a year = 24*330*P/COP kW.h
Energy for a year 187 671.52 kW.h
5.2.1.4 Centrifugation
When fermentation is complete the dead cells need to be removed from the
enzyme fermentation broth. This is done through centrifugation. Perry et al.
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(1984) has provided information for centrifugation power demand and the in-
formation is given in Table 5.16.
Table 5.16: Energy used for the centrifugation of the fermentation broth for the
FFase production process producing 14.43 tonnes per annum using the AOX pro-
duction strain
Item Energy consumption Unit
Automatic batch (constant speed) (E’) 26 kJ/kg
Centrifuge time 30 mins
Number of runs 2 times
Total time 60 mins
Number of operating hours in a year (t) 26*2*30mins 26 hours
Incoming flowrate (F) 2.07 kg/hr
Energy for a year (E = F*E’*t) 0.39 kW.h
5.2.1.5 Refrigeration
Once the enzyme fermentation broth has been sent through the centrifuge, its
will pass through an ultrafiltration plant where all the remaining contaminants
are removed. The enzyme finally needs to be stored in a cool store room at 4◦C.
This cool room is essential for the preservation of the enzyme and to maintain
its enzymatic activity. To calculate the energy needed for refrigeration, some
assumptions had to be made. Firstly, then specific heat of the enzyme broth
was taken to be that of water. This assumption was made because there is
no information available for the enzymatic broth and it exists in a watery
broth form, so the specific heat was taken to be 4.186 kJ/kg.K. The second
assumption was that the coefficient of performance for the refrigeration was
assumed to be 3.5 (Aneke et al., 2012). This was made because there will be
heat absorption through the walls of the cold room and the actual walls of the
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room will all be cooled during the cooling process. The following equation was
proposed by Çengel and Boles (2007):
COPR =
desired output
required input
= qL
Wnet,in
Therefore,
Wnet,in =
qL
COPR
The calculations are shown in Table 5.17.
Table 5.17: Energy used for the refrigeration of the fermentation broth for the FFase
production process producing 14.43 tonnes per annum using the AOX production
strain
Item Energy consumption Unit
Mass in (M) 1.823 kg/hr
Cpstainlesssteel 4.186 kJ/kg.K
dT 21 K
Power (E’) = M.Cp.dT 0.045 kW
Number of hours in a year (t) 24*330 hours
Energy required (E = E’*t) 352.460 kW.h
Coefficient of performance (COP) * 3.5
Energy required for a year (= E / COP) 100.703 kW.h
* The coefficient of performance (COP) specification was influenced on work by Aneke et al. (2012)
where it was mentioned that a formidable COP for vapour compression refrigeration was 3.5.
5.2.1.6 Total Energy Consumption
To calculate the total energy needed to run a FFase production facility that
produces 14.43 tonnes per annum, the sum of all the energy requirements is
taken and the total energy consumption is given in Table 5.18.
The comparison of the energy required for all scales of production is shown
in Table 5.19. The energy consumption increases proportionally according to
the production scale.
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Table 5.18: Total energy used for the FFase production process producing enough
enzyme to supply for a scFOS production facility of 2 000 tpa (producing 14.43
tonnes per annum using the AOX production strain)
Item Energy consumption Unit
Energy consumption for sterilisation 91.60 kW.h
Energy consumption for compressed air 28 995.11 kW.h
Energy consumption for agitation 1 332.40 kW.h
Energy consumption for temperature control 187 671.52 kW.h
Energy consumption for centrifugation 0.39 kW.h
Energy consumption for refrigeration 100.70 kW.h
Total energy consumption 218 191.72 kW.h
5.2.2 ScFOS Production Process
The scFOS production energy balance was done using enthalpy flows from
the incoming and outgoing components of each unit operation of the process.
Figure 5.1 shows the process flow diagram indicating the the energy loss by
the dark grey arrows and the energy input by the light grey arrows.
This chemical process had many complex carbohydrates involved in it.
Physical properties of some of the compounds were obtained but not all of
them because of the lack of knowledge of these complex carbohydrates. The
physical properties are shown in Table B.1, where some of the components
such as α-cyclodextrin and β-cyclodextrin were taken as reference compounds
for the higher molecular weight fructooligosaccharides. The trend in Figure
5.2 was that the heat capacity increase linearly with molecular weight, and if
this is correlated with Table B.1 and the trend-line in Figure 5.2, there is a
good fit to the curve.
The heat capacity model development from Figure 5.2 allowed all the ne-
cessary thermodynamic data to be obtained so that the energy balance around
the scFOS production process could be completed.
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Figure 5.1: Process flow diagram showing the heat flows within the scFOS produc-
tion process. The light grey arrows indicate where heat/energy is put into the system
and the dark grey arrows indicate where heat/energy is lost to the environment.
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Figure 5.2: Heat capacity model to determine the heat capacity of complex organic
compunds such as short chain fructooligosaccharides. The model fits well showing
an R squared value of 0.9986.
The sucrose and the FFase entered the reactor, R-102 and were subjected
to heating where the reaction temperature was specified to be 60◦C. Table
5.20 shows the information about the energy required to heat all the relevant
components in the reactor.
When the component in the reaction mixture leave the reactor, the energy
is assumed to be lost from the time it moves from the reactor to the buffer
tank, and then to the SMB chromatography column. The reaction mixture
then enters the SMB column and is heated to 60◦C, where the chromatographic
separation takes place. The energy required to heat the components is given in
Tables 5.21 and 5.22. The sum of these two energy figures should correspond
to the energy required to heat the reaction mixture in the reactor.
The most energy intensive operation in the scFOS production process is
the spray drying of the ‘wet’ scFOS to ensure that all the moisture is removed
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. MASS AND ENERGY BALANCE 109
Table 5.20: Energy input to reactor R-102 in figure 4.6
Component Flow rate (kg/h) Mass % Enthalpy (kW)
Kestose (GF2) 94.17 12.49 1.20
Nystose (GF3) 125.56 16.65 1.47
1F -F-Nystose (GF4) 23.54 3.12 0.27
GF5 9.36 1.24 0.11
GF6 3.74 0.50 0.04
GF7 1.87 0.25 0.02
Fructose (F) 14.97 1.99 0.17
Glucose (G) 86.08 11.42 1.01
Sucrose (GF) 46.52 6.17 0.56
Water 345.81 45.52 13.92
FFase 2.41 0.32 0.10
Total 754.03 100 18.90
Table 5.21: Energy input to SMB chromatography column R-103 in figure 4.6
Component Flow rate (kg/h) Mass % Enthalpy (kW)
Kestose (GF2) 89.39 15.48 1.14
Nystose (GF3) 119.19 20.65 1.40
1F -F-Nystose (GF4) 22.34 3.87 0.26
GF5 8.88 1.54 0.10
GF6 3.55 0.62 0.04
GF7 1.78 0.31 0.02
Fructose (F) 0.75 0.13 0.01
Glucose (G) 4.30 0.74 0.05
Sucrose (GF) 2.32 0.40 0.03
Water 324.79 56.26 13.23
Total 577.31 100 16.28
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Table 5.22: Energy input to SMB chromatography column R-103 in figure 4.6
Component Flow rate (kg/h) Mass % Enthalpy (kW)
Kestose (GF2) 4.70 2.73 0.060
Nystose (GF3) 6.27 3.64 0.073
1F -F-Nystose (GF4) 1.18 0.68 0.013
GF5 0.47 0.27 0.005
GF6 0.19 0.11 0.002
GF7 0.09 0.05 0.001
Fructose (F) 14.21 8.24 0.17
Glucose (G) 81.72 47.37 0.96
Sucrose (GF) 44.16 25.60 0.53
Water 17.09 9.91 0.69
Total 172.49 100 2.51
and that it is ready for packaging and sales. The ‘wet’ scFOS enters the spray
drying chamber where it is sprayed through a nozzle. The chamber is already
heated with hot dry air at 180◦C. The hot dry air absorbs almost all of the
moisture in the scFOS leaving a dry powder and the hot ‘wet’ air leaves the
spray dryer and is sent to a purge. A lot of hot dry air is needed to perform
the moisture removal and Huang and Mujumdar (2007) provided valuable inlet
air feed correlations with regard to the design parameters of the spray dryer.
Table 5.23 shows the energy required to heat up the air and Table 5.25 shows
the energy required to heat up the components that need to be dried.
Table 5.23: Energy input for hot dry air to spray dryer F-104 in figure 4.6
Component Flow rate (kg/h) Mass % Enthalpy (kW)
Hot dry air 7 563.00 100 327.26
Total 7 563.00 100 327.26
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The spray dryer also needs the air to be extracted from the process. To
determine the duty of the fan that needs to extract the air, the fan curves are
used in appendix H. The volumetric air flow rate corresponds to the duty at
a given propeller speed. For the given situation, Table 5.24 shows the energy
needed to run the fan in the spray dryer.
Table 5.24: Energy input for the extraction fan in the spray dryer F-104 in figure
4.6
Component Flow rate (m3/h) Duty (kW)∗
Hot dry air 6 290.20 1.60
Total 6 290.20 1.60
* Duty figure taken from Figure H.1 in appendix H.
Table 5.25: Energy input for heating scFOS in spray dryer F-104 in figure 4.6
Component Flow rate (kg/h) Mass % Enthalpy (kW)
Kestose (GF2) 89.39 15.48 4.57
Nystose (GF3) 119.19 20.65 5.60
1F -F-Nystose (GF4) 22.34 3.87 1.04
GF5 8.88 1.54 0.40
GF6 3.55 0.62 0.14
GF7 1.78 0.31 0.07
Fructose (F) 0.75 0.13 0.03
Glucose (G) 4.30 0.74 0.20
Sucrose (GF) 2.32 0.40 0.11
Water 324.79 56.26 52.91
Total 577.31 100 65.09
The raffinate from the SMB chromatography column is also treated in the
scFOS production process as there are still valuable sugars that are present
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in this stream (stream 8 in Figure 4.6). To remove the unwanted moisture in
the raffinate stream, an evaporator is used. The evaporator operates at 105◦C
(temperature choice influenced by work done by Pridgeon and Badger (1924)).
The energy consumption from the evaporator is given in Tables 5.26 and 5.27.
Table 5.26: Energy input for the evaporator to treat the by-product, E-101 in
figure 4.6
Component Flow rate (kg/h) Mass % Enthalpy (kW)
Kestose (GF2) 4.470 3.08 0.106
Nystose (GF3) 5.960 4.10 0.130
1F -F-Nystose (GF4) 1.117 0.77 0.024
GF5 0.444 0.31 0.010
GF6 0.178 0.12 0.004
GF7 0.089 0.06 0.002
Fructose (F) 13.501 9.29 0.292
Glucose (G) 77.630 53.41 1.698
Sucrose (GF) 41.955 28.87 0.942
Total 145.343 100 3.208
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Table 5.27: Energy input for the evaporator to treat the by-product, E-101 in
figure 4.6
Component Flow rate (kg/h) Mass % Enthalpy (kW)
Kestose (GF2) 0.235 0.95 0.0056
Nystose (GF3) 0.314 1.27 0.0068
1F -F-Nystose (GF4) 0.059 0.24 0.0013
GF5 0.023 0.09 0.0005
GF6 0.009 0.04 0.0002
GF7 0.005 0.02 0.0001
Fructose (F) 0.711 2.87 0.0154
Glucose (G) 4.086 16.51 0.0893
Sucrose (GF) 2.208 8.92 0.0496
Water 17.094 69.09 1.2929
Total 24.750 100 1.4621
The sum of all the energy is given in Table 5.28, where the total annual
power consumption is shown for an scFOS production rate of 2 000 tonnes per
annum.
Table 5.28: Total energy needed for the scFOS production process, focusing on 2
000 tpa (figure 4.6)
Unit operation Energy consumption Unit
Bioreactor (R-102) 18.90 kW
SMB chromatography column (R-103) 18.80 kW
Spray dryer (F-104) 393.95 kW
Evaporator (E-101) 4.67 kW
Total 436.22 kW
Total energy for a year 3 454 862.40 kW.h
The summary of the total energy consumption is given in Table 5.29 where
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it shows that the spray dryer uses a lot of energy compared to the other unit
operations. The total amount is given at the bottom of the table in kilowatts
and kilowatt hours.
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Chapter 6
Process Economics
6.1 Economies of Scale
One of the main aims of this project was to discover the economic viability
of the implementation of a β-D-fructofuranosidase and a scFOS plant to be
built in South Africa. Various scales of production were looked at to see what
would be the minimum scale of production that would allow the plant to be
able to succeed. An important factor to consider in the scale-up of FFase
and scFOS production was economies of scale. A company will experience an
economy of scale if the cost per unit decreases as the output volume increases
(Fourie et al., 2008). In other words, as the levels of production increase, the
equipment prices should become less per unit volume of the piece of equipment.
This can also apply to some of the bulk raw material prices. Therefore, if one
were to increase the scale of production, it would become more profitable for
the company provided that the company reaches its sales target.
This is the biggest challenge of the company because it is good to know
that the company will enjoy a higher IRR at larger production levels, but
this is under the assumption that all the manufactured product is sold. This
is an optimist view, but another way to approach this challenge is to find
out information about the market, make a pessimistic assumption and try to
determine what is the minimum level of production that one can produce at
in order to achieve an IRR of a least 30%.
116
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6.2 Process Costing
6.2.1 Assumptions
The process costing model is based on a template suggested by Choi and Lee
(1997) and in some aspects of the costing of the FFase and scFOS production
plant, various assumptions needed to be made. The following assumptions
were made:
• ScFOS is sold at a price of US$5-10/kg.
• The project life is 10 years.
• Tax rate is given as the South African governmental standard of 28%.
• Salvage value of plant is 10% of initial value.
• The fixed capital investment is implemented in the first two years of the
project with 60% of the money being used in the first year and 40% of
the money being used in the second year.
• The amount of labourers working in the facility was assumed to be 30
people.
• The wage for the labourers was R25 per hour. This was assumed from
South Africa’s national wage website (www.mywage.co.za).
• The working capital for the project was assumed to be 20% of the fixed
capital investment (Turton et al., 2008).
• The process costing method that was developed was partially based on
work done by Choi and Lee (1997), Haas et al. (2006) and Petrides
(2000).
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6.2.2 Scenarios
The project proposes some costing scenarios to choose the best conditions for
the production of FFase and scFOS. Figure 6.1 gives an illustrative view of
the different cases that are to be looked at. The first scenario is aimed at
determining at what price the FFase needs to be sold at in order to achieve an
IRR of at least 30% considering both production strains (AOX and GAP) as
well as at different production levels.
Regarding the scFOS production; there are four scenarios that are looked
at (scenario 2-5). Scenario 2 looks at the prospect of self producing the FFase
using the GAP production strain to be able to supply for a local scFOS produc-
tion plant (using results generated from the consortium’s experiments) com-
pared to using an external toll manufacturer to produce the enzyme. The
external toll manufacturer would typically have a higher price compared to
local production. The capital cost of equipment is looked at for both the
FFase and scFOS production facilities as well as the operating costs. This
scenario is based on the assumption that the FFase and the scFOS production
plants run independently, but that the scFOS production plant is supplied
with the amount of enzyme it needs from the FFase production plant.
Scenario 3 is the same as scenario 2 except it uses AOX instead of GAP. It
looks at the prospect of self producing the FFase using the AOX production
strain to be able to supply for a local scFOS production plant (using results
generated from the consortium’s experiments) compared to using an external
toll manufacturer to produce the enzyme. Scenario 4 and 5 are also similar to
scenario 2 and 3 except that the best results from literature are used instead of
the best results obtained from the experiments performed by the consortium.
All these scenarios are compared to each other in order to find the most feasible
option, which would then be the best option to take if this project would come
into fruition.
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Figure 6.1: FFase and scFOS project mind map showing the different scenarios
that are proposed within the project. Two sets of results are used; the best from
literature as well as the best results obtained from the experiments performed by the
scientists within the scFOS project research group.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. PROCESS ECONOMICS 120
6.2.3 RiskSim
When performing a costing analysis on a large project, the requirement is to
estimate the capital and operating expenditure as close as possible to what one
would think would be an accurate portrayal of the cost estimation. Accurate
quotes need to be obtained from potential suppliers for equipment as well as
raw materials. Once all the prices are known the costing analysis can be done
with the use of a costing worksheet.
In order for the cost estimation to be as realistic as possible, the Microsoft
Excel® add-in, RiskSim was used to perform many Monte Carlo analyses on
the different scenarios that are proposed in this project. The random number
generator in Microsoft Excel®(2010) was used to generate random cost devi-
ations so that a Monte Carlo simulation can be done on the costing of the
project at the designated production scale.
Figure 6.2: A cumulative chart and histogram of a simulation run to 3 000 iter-
ations. The results of the simulation have the following results: mean = 0.998, st.
dev. = 0.116, mean st. error = 0.002, minimum = 0.800, first quartile = 0.898,
median = 0.998, third quartile = 1.097, maximum = 1.200, skewness = 0.0183.
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RiskSim, the Microsoft Excel (2010)® add-in, facilitates a Monte Carlo
simulation by providing: nine random number generator functions, the abil-
ity to be able to set the seed for the random number generator, automatic
repeated sampling for simulation, frequency distribution of simulation results,
histogram and cumulative distribution charts. The random number generator
in Microsoft Excel (2010)® is used to generate any number in the range that
you specify. RiskSim then uses the random number generator to generate up
to a maximum of three thousand iterations. Figure 6.2 shows an example of
a RiskSim cumulative chart and histogram, showing three thousand iterations
between 0.8 and 1.2. For the costing model in this project, the prices for the
equipment are assumed to deviate 20% either way of its given value.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. PROCESS ECONOMICS 122
6.2.4 Costing Worksheet
After the design and mass and energy balance of the process, a costing work-
sheet needed to be developed so that the important values such as capital
expenditure (CAPEX) and operating expenditure (OPEX) can be calculated
and ultimately work out the feasibility of the project.
The CAPEX is the figure that possible investors would like to know as this
would be the money that they would have to put in, in order for the project
to start. The investors also like to know the IRR of the project so that they
will know what type of return they can expect back from their initial money
input.
Table 6.1 shows the first section of the costing analysis where the capital
expenditure is estimated. The construction of this worksheet was obtained
from many different sources. The costing worksheet was based on two models
proposed by Choi and Lee (1997) and Petrides (2000). It must be noted
that the equipment prices for both the FFase and the scFOS production were
obtained from the references shown and this was based on an scFOS production
scale of 10 000 tonnes per annum and a corresponding FFase production scale
(using the AOX production strain) of 72 tonnes per annum. The costs for the
different production scales were adjusted according to the ‘six tenths’ rule.
Once a basic idea of a model was developed, the model had to be adjusted
and changed according to the requirements of this project. Quotes for equip-
ment needed to be obtained from reliable suppliers so that the model was
accurate and had realistic estimations. In Table 6.1, it can be seen that the
equipment quotes have been obtained from a few suppliers. SIRIUS Engineer-
ing (Pty) Ltd is an engineering consulting company in Paarl, South Africa that
performed a costing analysis on the capital expenditure of industrial FFase and
scFOS production related to this project. They have knowledge of local sup-
pliers of equipment and their equipment reference has been shown in Table 6.1.
SIRIUS Engineering (Pty) Ltd were also supplied with process design and the
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equipment sizing, where they performed their costing analysis on that basis.
They performed their own capital cost estimation to be used as a verification
of the estimate performed in this project. De Dietrich Process Systems Ltd
is a global company that focuses on manufacturing process equipment. The
South African branch exists in Boksburg, Gauteng.
Table 6.2 shows the operating costs of the costing model, where all the
raw materials and operating costs of the company were looked at. Table 6.2 is
also the second half of the entire costing worksheet and the total annual costs
for the entire project is given as the sum of all the costs in both Tables 6.1
and 6.2. Sigma-Aldrich® is a company that, amongst others, manufactures
and supplies chemicals. The prices for the necessary chemicals needed for this
process were obtained from Sigma-Aldrich®. Alibaba.com® is a global trading
site based in Asia where one can search for equipment and chemical product
and be put into contact with suppliers. Some of the prices obtained in this
costing worksheet were from suppliers that were contacted via email and were
based in China.
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6.2.5 FFase Production
6.2.5.1 Scenario 1 - FFase production using GAP and AOX
production strain
The first scenario compares the production of β-D-fructofuranosidase using
the GAP and the AOX strains. From the experiments performed by the sci-
entists it was found that when comparing GAP and AOX, AOX performed
better where it produced a more concentrated enzyme. GAP also produced
an appreciable amount of enzyme but the concentration level was not to the
same degree as AOX.
Because AOX produced a more concentrated enzyme compared to GAP
production process, the fermenter size for the AOX production process was
smaller than GAP when producing the same amount of enzyme. As a result,
the capital expenditure for the AOX production process was less than the GAP
production process.
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Capital Expenditure
The capital expenditure for the FFase production system using GAP as the
production strain was costed. Table 6.3 shows the capital expenditure (CAPEX)
also known as the direct fixed capital (DFC) of an FFase production plant us-
ing GAP at different production levels corresponding to the respective scFOS
production scale it would supply to.
Table 6.3: Enzyme production direct fixed capital using the GAP production strain
Item ScFOS production scale (tpa)
2 000 5 000 10 000 20 000 30 000
FFase production scale (tpa)
19 48 95 191 286
Cost (Rand ’000)
Land 1 807 4 517 11 877 18 072 27 108
TOTAL 1 807 4 517 11 877 18 072 27 108
Organism preparation laboratory 1 127 1 953 2 953 4 486 5 722
Fermenters 790 1 369 2 070 3 145 4 012
Industrial chiller 101 175 264 401 512
Spray balls 14 23 35 54 69
Centrifuge 44 77 116 176 224
Scrubber 44 77 116 176 224
Ultrafiltration 44 77 116 176 224
Rotary yeast dryer 1 352 2 343 3 543 5 383 6 866
Storage tank 146 253 354 538 741
TOTAL 3 662 6 345 9 595 14 578 18 593
Installation 2 563 4 442 6 717 10 205 13 015
Process piping 1 282 2 221 3 358 5 102 6 508
Instrumentation 1 465 2 538 3 838 5 831 7 437
Insulation 110 190 288 437 558
Electrical 366 635 960 1 458 1 859
Buildings 1 648 2 855 4 318 6 560 8 367
Yard improvement 549 952 1 439 2 187 2 789
Auxiliary facilities 1 465 2 538 3 838 5 831 7 437
TOTAL 9 448 16 371 24 755 37 611 47 971
Engineering 3 277 5 679 8 588 13 047 16 641
Construction 4 588 7 951 12 023 18 266 23 297
TOTAL 7 866 13 630 20 610 31 314 39 938
Contractor’s fee 1 049 1 817 2 748 4 175 5 325
Contingency 2 097 3 635 5 496 8 350 10 650
Working Capital 4 824 8 360 12 641 19 206 24 495
OTHER COSTS (OTC) 7 970 13 812 20 885 31 731 40 470
CAPEX 30 753 54 677 87 722 133 306 174 080
Table 6.4 shows the fixed capital expenditure of an FFase production plant
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using AOX as the production strain and it can be seen that less enzyme of
the AOX production strain is needed compared to the GAP production strain
for a respective production level of scFOS because AOX produces a more
concentrated enzyme compared to GAP.
Table 6.4: Enzyme production direct fixed capital using the AOX production strain
Item ScFOS production scale (tpa)
5 000 10 000 20 000 30 000 40 000
FFase production scale (tpa)
14 36 72 144 216
Cost (Rand ’000)
Land 1 807 4 518 9 000 18 000 27 000
TOTAL 1 807 4 518 9 000 18 000 27 000
Organism preparation laboratory 954 1 653 2 500 3 789 4 833
Fermenters 689 1 194 1 806 2 737 3 491
Industrial chiller 86 149 226 343 437
Spray balls 112 194 294 446 568
Centrifuge 37 65 98 149 189
Scrubber 37 65 98 149 189
Ultrafiltration 37 65 98 149 189
Rotary yeast dryer 1 145 1 984 3 000 4 547 5 800
Storage tank 124 214 324 491 626
TOTAL 3 222 5 584 8 443 12 798 16 323
Installation 2 256 3 908 5 910 8 958 11 426
Process piping 1 128 1 954 2 955 4 479 5 713
Instrumentation 1 289 2 234 3 377 5 119 6 529
Insulation 97 168 253 384 490
Electrical 322 558 844 1 280 1 632
Buildings 1 450 2 513 3 800 5 759 7 345
Yard improvement 470 815 1 233 1 868 2 383
Auxiliary facilities 1 289 2 233 3 377 5 119 6 529
TOTAL 8 314 14 406 21 784 33 018 42 112
Engineering 2 884 4 998 7 557 11 454 14 609
Construction 4 038 6 997 10 580 16 036 20 452
TOTAL 6 922 11 994 18 136 27 490 35 061
Contractor’s fee 923 1 599 2 418 3 665 4 675
Contingency 1 846 3 198 4 836 7 331 9 350
Working Capital 4 245 7 356 11 124 16 860 21 504
OTHER COSTS (OTC) 7 014 12 153 18 378 27 856 35 529
CAPEX 27 279 48 656 75 742 119 162 156 024
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Raw material costs
Table 6.5 shows the operating capital expenditure of an FFase production plant
using GAP as the production strain. Using the GAP production strain will
have higher operating costs as the fermentation volume is larger when using
GAP.
Table 6.5: Enzyme production operating costs for the various production levels
using the GAP production strain
Item ScFOS production scale (tpa)
2 000 5 000 10 000 20 000 30 000
Production scale (tpa)
19 48 95 191 286
Cost (Rand ’000)
Depreciation 5 535 9 842 15 790 23 995 31 334
Maintenance material 553 984 1 579 2 400 3 133
Insurance 308 547 877 1 333 1 741
Local taxes 615 1 094 1 754 2 666 3 482
Factory expenses 1 538 2 734 4 386 6 665 8 704
DFC DEPENDENTS 8 459 15 200 24 386 37 059 48 394
Operating labour 462 1 155 2 310 4 620 6 930
Maintenance labour 162 404 809 1 617 2 426
Fringe benefits 249 624 1 247 2 495 3 742
Supervision 125 312 624 1 247 1 871
Operating supplies 46 116 231 462 693
Laboratory 69 173 347 693 1 040
LABOUR DEPENDENTS 1 113 2 784 5 567 11 134 16 701
ADMIN & OVERHEADS 524 1 310 2 620 5 239 7 859
Raw materials
Glycerol (batch) 304 761 1 516 3 044 4 565
Glycerol (fed batch) 356 891 1 774 3 562 5 344
Yeast extract 146 365 727 1 462 2 192
Phosphoric acid 85% 506 1 265 2 519 5 058 7 588
Calcium sulphate 8 19 38 77 116
Potassium sulphate 198 495 986 1 979 2 969
Magnesium sulphate-7H2O 151 378 752 1 511 2 266
Potassium hydroxide 17 42 83 166 249
Caustic soda 1% 1 2 4 8 12
Sodium benzoate 0.2% w/w 13 33 66 132 197
Potassium sorbate 0.2% w/w 2 5 9 19 28
Sorbitol 30% 56 140 279 560 840
TOTAL 1 758 4 394 8 754 17 578 26 366
Utilities
Electricity 183 457 910 1 826 2 739
TOTAL 183 457 910 1 826 2 739
OPEX 12 127 24 144 42 237 72 835 102 059
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Table 6.6: Enzyme production operating costs for the various production levels
using the AOX production strain
Item ScFOS production scale (tpa)
2 000 5 000 10 000 20 000 30 000
Production scale (tpa)
14 36 72 144 216
Cost (Rand ’000)
Depreciation 4 910 8 758 13 634 21 449 28 084
Maintenance material 491 876 1 363 2 144 2 808
Insurance 273 487 757 1 192 1 560
Local taxes 546 973 1 515 2 383 3 120
Factory expenses 1 364 2 433 3 787 5 958 7 801
DFC DEPENDENTS 7 583 13 526 21 056 33 127 43 375
Operating labour 396 990 1 980 3 960 5 940
Maintenance labour 139 347 693 1 386 2 079
Fringe benefits 214 535 1 069 2 138 3 208
Supervision 107 267 535 1 069 1 604
Operating supplies 40 99 198 396 594
Laboratory 59 149 297 594 891
LABOUR DEPENDENTS 954 2 386 4 772 9 544 14 315
ADMIN & OVERHEADS 449 1 123 2 245 4 491 6 736
Raw materials
Glycerol (batch) 257 643 1 280 2 560 3 840
Glycerol (fed batch) 70 176 350 700 1 049
Methanol (fed batch) 77 192 382 763 1 145
Yeast extract 123 309 615 1 230 1 844
Phosphoric acid 85% 427 1 068 2 128 4 255 6 383
Calcium sulphate 7 16 33 65 98
Potassium sulphate 167 418 833 1 665 2 498
Magnesium sulphate-7H2O 128 319 635 1 271 1 906
Potassium hydroxide 14 35 70 140 209
Caustic soda 1% 1 3 7 14 20
Sodium benzoate 0.2% w/w 10 25 50 99 149
Potassium sorbate 0.2% w/w 1 4 7 14 21
Sorbitol 30% 42 106 211 423 634
TOTAL 1 325 3 313 6 599 13 198 19 796
Utilities
Electricity 142 355 707 1 425 2 138
TOTAL 142 355 707 1 425 2 138
OPEX 10 454 20 704 35 381 61 788 86 367
Table 6.6 shows the operating expenditure of an FFase production plant
using AOX as the production strain.
Figure 6.3 shows the expenditure of an FFase production facility using the
GAP production strain at different production levels. The comparison between
TPDC, TPIC, DFC and OPEX is observed as the production levels increase.
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Figure 6.3: The expenses of an enzyme production facility producing FFase with
GAP production strain (TPDC = total plant direct cost, TPIC = total plant indirect
cost, DFC = direct fixed capital, OPEX = operating expenditure).
Figure 6.4 shows the expenditure of an FFase production facility using
the AOX production strain at different production levels. The comparison
between TPDC, TPIC, DFC and OPEX is again observed as the production
levels increase.
Figure 6.5 shows a DFC/CAPEX and OPEX comparison between the GAP
and AOX production strains when producing FFase. AOX is more attractive
to use as it costs less money to buy and run the enzyme production facility.
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Figure 6.4: The expenses of an enzyme production facility producing FFase with
AOX production strain.
Figure 6.5: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
6.2.6 scFOS Production
6.2.6.1 Scenario 2 - ScFOS production, self producing FFase,
comparing GAP and AOX production strains
Producing FFase and scFOS in the same facility will have the highest capital
costs and operating costs. However, even though this option shows to be the
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most expensive, it will still be a safe venture at production levels of 2 000
tonnes per annum and above. Figure 6.6 shows the expenditure using FFase
that has been produced with GAP and Figure 6.7 shows the expenditure using
FFase that has been produced with AOX.
Figure 6.6: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
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Figure 6.7: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
6.2.6.2 Scenario 3 - ScFOS production, buying locally produced
FFase, comparing GAP and AOX production strains
The second option to produce scFOS is to buy FFase from a local producer.
This option will have less capital and operating expenditure compared to self
producing the enzyme, but the price of the enzyme is based on the FFase
production facility making a 30% IRR on sales. At low scFOS production
levels and thus low FFase production levels, the price of the enzyme will be
high, which is unfavourable for the scFOS producer. As the production level
increases, the price of the enzyme will decrease. Figures 6.8 and 6.9 show the
expenditure for scFOS production buying a GAP produced FFase and an AOX
produced FFase respectively.
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Figure 6.8: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
Figure 6.9: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
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6.2.6.3 Scenario 4 - ScFOS production, buying FFase from a toll
manufacturer, comparing GAP and AOX production
strains
The toll manufacturer provides the best option for scFOS production. They
can supply FFase at the best price. This is due to the nature of a toll man-
ufacturing facility, where they have many application and supply to many
industries, they have the freedom to lower prices to a very competitive level.
Figures 6.10 and 6.11 compare the two production strains.
Figure 6.10: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
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Figure 6.11: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
6.2.6.4 Scenario 5 - ScFOS production, buying locally produced
FFase at an export price, comparing GAP and AOX
production strains
The final option that was looked at was the possibilty of buying FFase from
a local supplier that offered the enzyme at an export price. This is under
the assumption that the FFase production facility supplies to many different
companies and can afford to drop their price to a low amount. This would be
ideal for scFOS production as the enzyme would now be cheap and operating
costs would be lower for scFOS production. Again, Figures 6.12 and 6.13
compare the GAP and AOX production strains respectively.
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Figure 6.12: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
Figure 6.13: The expenses of an FFase production facility comparing the GAP
and AOX production strains, corresponding to the scFOS production scale that the
enzyme production facility would supply to.
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Table 6.7: Economic summary of scFOS production using the AOX gene at 2 000
tonnes per annum, comparing different scenarios
Production level Scenario 2 Scenario 3 Scenario 4 Scenario 5
2 000 tpa Unit Make self Buy local Buy export Buy toll
CAPEX ZAR (millions) 99.8 75.7 75.7 75.7
NPV results
Mean ZAR (millions) 196.4 189.7 216.6 238.5
St. Dev. ZAR (millions) 77.7 78.8 78.9 77.9
Mean St. Error ZAR (millions) 2.5 2.5 2.5 2.5
Minimum ZAR (millions) 38.6 31.5 66.1 89.4
First quartile ZAR (millions) 127.9 123.9 147.6 175.3
Median ZAR (millions) 201.0 184.6 216.1 233.2
Third quartile ZAR (millions) 260.8 259.1 282.4 302.4
Maximum ZAR (millions) 370.5 367.8 395.9 392.1
Skewness -0.0004 0.1026 0.0339 0.0503
Prob NPV > 0 100% 100% 100% 100%
IRR Results
Mean % 38.0 42.0 45.0 46.6
St. Dev. % 8.4 10.0 9.8 9.5
Mean St. Error % 0.3 0.3 0.3 0.3
Minimum % 17.9 18.8 22.9 25.9
First quartile % 31.5 34.0 37.2 39.0
Median % 38.8 42.8 45.5 46.7
Third quartile % 44.8 49.5 53.0 53.9
Maximum % 55.9 66.4 66.7 68.3
Skewness -0.1774 -0.0844 -0.0265 -0.0161
Prob IRR > 25% % 92% 96% 99% 100%
6.2.6.5 Economic Summary
The results in this chapter have shown that is it always more favourable to use
AOX as the production strain when producing FFase and thus scFOS. Table
6.7 shows a comparison and statistical analysis of producing scFOS using an
FFase produced with AOX, at a production rate of 2 000 tonnes per annum,
comparing the scenario explained in this chapter.
After careful marketing and economic investigation it was decided that the
most realistic manner to produce scFOS was to self produce the FFase in the
same facility as scFOS production. This was due to the low demand of the
enzyme and even though there is a higher capital cost, the economic analysis
showed that the facility will still make good profit at production levels of 2 000
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tonnes per annum and above. Table 6.8 shows the base, worst and best case
scenarios when producing scFOS using FFase that has been produced with
AOX, comparing different production levels.
It can be seen in Table 6.8, that positive NPV’s are attained for all cases
expect for that of the worst case scenario producing 500 tonnes per annum of
scFOS. Not surprisingly, the highest NPV is attained at the highest production
level and the best case. The same pattern occurs with the IRR in Table 6.8.
This is because the NPV and the IRR are mutually dependent.
Table 6.8: Economic summary of scFOS production using the AOX gene at 2 000
tonnes per annum, comparing different scenarios
ScFOS production scale (tpa)
500 1 000 2 000 5 000 10 000
IRR
Base Case 20.6 29.0 37.9 53.4 61.0
Worst Case 0.5 8.6 16.8 31.7 36.0
Best Case 37.3 47.0 57.5 74.5 84.8
NPV
Base Case 24.2 77.3 199.3 666.9 1 324.8
Worst Case -20.9 -7.2 39.4 301.0 591.3
Best Case 65.7 154.7 345.0 997.2 1987.3
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Results and Discussion
7.1 Scenario Comparisons
7.1.1 FFase Production
7.1.1.1 Scenario 1 - FFase production using GAP and AOX
production strains
The selling price of the enzyme of β-D-fructofuranosidase is determined by
pitching a price that will enable the enzyme production facility to attain an
IRR of 30%. Figure 7.1 shows the price of the pure protein against the pure
protein production scale. Typically, the enzyme would be sold in a broth form
as the enzyme dosage is very low for scFOS production. It also makes for
easier handling when using the enzyme in broth form. Figure 7.1 illustrates
the effect of economies of scale where the price drops significantly initially and
flattens out as the production scale increases to much larger amounts. The
FFase produced using the AOX gene can be sold for a lower price because it
produces more enzyme in a smaller sized fermenter compared to the FFase
produced with the GAP gene.
Figure 7.2 shows a comparison between the GAP and the AOX production
strains with FFase in the broth form. The prices show to be very similar but
the difference between the two production strains is that the AOX has a higher
activity compared to the GAP. There is more protein concentrated in the AOX
broth. A potential customer would have to buy less FFase produced with AOX
141
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compared to the GAP produced FFase. This could be a selling point in the
manufacturing of this enzyme. An alternative option could be to dilute the
enzyme produced with AOX to the same concentration as a GAP produced
FFase or the industry standard. This would enable more enzyme to be sold
and thus more profit in the enzyme production facility.
Figure 7.1: Enzyme selling price of pure protein in order for the facility to obtain
a 30% IRR.
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Figure 7.2: Enzyme selling price per fermentation broth in order for the facility to
obtain a 30% IRR.
7.1.2 ScFOS Production
7.1.2.1 Scenario 2 - scFOS production at different production
levels using FFase that is produced in the same facility as
the scFOS, comparing GAP and AOX production strains
There are five scenarios that are considered in the project and four scenarios
specifically to produce scFOS in this project (scenarios 2-5). 2) ScFOS can be
produced by using an FFase that is produced in the same facility as scFOS.
The enzyme production process feeds into the scFOS production process and
all the manufacturing takes place in one facility. 3) ScFOS can be produced
using an enzyme that is produced in a separate independent facility and that
facility will sell FFase to the scFOS production plant. 4) ScFOS can be made
using an enzyme that is bought from a toll manufacturer. These are companies
which produce many different enzymes and have the capacity to manufacture
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an enzyme of choice on demand. 5) ScFOS can be produced using an enzyme
that is produced in a separate independent facility and that facility will sell
FFase to the scFOS production plant an an export price.
Figure 7.3: ScFOS production using FFase that has been produced in the same
facility as the scFOS, comparing the GAP and AOX strains.
Figure 7.3 shows the scenario where scFOS is produced by self-producing
FFase in the same facility and the production strain of AOX and GAP are
compared. The FFase is produced in the first part of the process and the
enzyme broth that is produced is fed straight to the scFOS production process.
As the AOX gene produces a more concentrated enzyme, it would use less
fermenter volume which would lessen the equipment cost.
Figure 7.3 shows that the IRR is higher using AOX compared to GAP and
it is therefore better to produce scFOS while producing FFase with the AOX
production strain. As the production levels increase, the difference between
the two production strains increases at scFOS production levels between 2 000
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and 10 000 tonnes per annum. This difference then stays constant at scFOS
production levels greater than 10 000 tonnes per annum.
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7.1.2.2 Scenario 3 - scFOS production at different production
levels using FFase that is bought from a local producer
comparing GAP and AOX production strains
Figure 7.4: ScFOS production using FFase fermentation broth that has been
bought from a local FFase producer, comparing the GAP and AOX strains.
Figure 7.4 shows that when producing scFOS, a local enzyme production
facility can offer a better enzyme price when producing the FFase with the
AOX production strain compared to GAP. It can also be seen that at produc-
tion levels of 2 000 tonnes per annum, the scFOS production plant can achieve
a healthy IRR above 30%.
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7.1.2.3 Scenario 4 - scFOS production at different production
levels using FFase that is bought from an external toll
manufacturer, comparing GAP and AOX production
strains
The third point discussed in the different scenarios to produce scFOS con-
sidered the use of a toll supplier. A toll supplier is an enzyme production
company that has the capacity to produce many different enzymes. They
would produced the FFase as requested as well as many other enzymes to
other companies according to their specified requirements. Figure 7.5 shows
the comparison between the AOX and GAP production strains, where there
is not much difference in the price. The reason for this is due to the fact that
when producing scFOS, very little enzyme is needed to be added to the sucrose
to produce scFOS. This means that there won’t be a huge margin in difference
when considering all the costs of the entire model.
This figure also corresponds with Figure 7.1 where one can see that there
is not much difference at all with regards to the enzyme fermentation broth
price. The toll manufacturing price is based on a quote of £60 000 per 20 000
litres and the required fermenter volume needed for each respective production
strain. The costs for GAP is more expensive than AOX, but when considering
the entire costs for the whole production plant, the difference is not large.
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Figure 7.5: ScFOS production using FFase that has been bought an enzyme toll
manufacturer, comparing the GAP and AOX strains.
7.1.2.4 Scenario 5 - scFOS production at different production
levels using FFase that is bought from a local producer at
an export price, comparing GAP and AOX production
strains
An alternative buying option that was also investigated was the possibility of
buying FFase at an export price. This is the best price the FFase production
facility can offer, assuming that the enzyme production plant is producing
and selling at high enough quantities to be able to afford a lower selling price.
Figure 7.6 shows that when producing scFOS; an FFase that is bought with the
export price offered by the AOX production strain is more attractive compared
to FFase sold with the GAP production strain.
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Figure 7.6: ScFOS production using FFase that has been bought from a local FFase
producer offering the FFase at a competitive export price. The production strains of
GAP and AOX are compared. The GAP is selling at R847/kg of fermentation broth
and AOX is selling at R596/kg of fermentation broth.
7.1.2.5 Scenarios Summary
All the scenarios pose slightly different situations when regarding the IRR
at different production levels but at the same time, the curves show similar
trends with regards to their shape and the effect of economies of scale. Figure
7.7 shows scFOS production using the GAP production strain comparing four
different scenarios, namely: i) self-producing FFase in the same facility, ii)
buying FFase from a local producer at a price that would enable the supplier
to make a 30% IRR while only selling to one scFOS production facility. iii)
Using a toll manufacturer to supply the FFase for scFOS production, iv) buying
FFase from a local producer who would supply FFase at an export price. The
export price will be a price that is based on the FFase producer to make a
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30% on sale to many scFOS production companies.
Figure 7.7 shows that the most attractive option is to use a toll supplier.
The reason the toll supplier would be the most favourable is that a toll supplier
specialise in enzyme production so they would be able to provide an enzyme
price that is very competitive. Buying from a local producer is also a good
option but a potential problem with having an independent FFase producer
is that the two facilities are co-dependent. If the local producer happens to
receive better orders from elsewhere, the local scFOS production facility may
run into some trouble. The least attractive, but the safest option to produce
scFOS is to produce FFase and scFOS in one independent facility. This way
there are no external influencing factors that can cause problems with regard
to the scFOS production.
Figure 7.7: ScFOS production that compares all the different options of obtaining
the GAP produced FFase enzyme, namely: through self-production, buying from a
local producer, buying from a toll supplier, and buying from a local producer that
can supply at a low export price.
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Figure 7.8 shows the same information as Figure 7.7 but it focuses on
the lower scales of production. The lower areas of production are of interest
because it is more realistic to enter the scFOS market at these production
levels considering the estimated global market for scFOS. When looking at the
‘buy local’ option and the ‘self-produce’ option, the ‘buy local’ option becomes
increasingly more favourable a larger scales of production. This is because the
FFase supplier can afford to offer a better price as more enzyme is needed.
Figure 7.8: ScFOS production that compares all the different options of obtaining
the GAP prodcued FFase enzyme, namely: through self-production, buying from a
local producer, buying from a toll supplier, and buying from a local producer that
can supply at a low export price.
Figure 7.9 is based on the same idea as Figure 7.7, but Figure 7.9 looks
at the AOX production strain. The trends are very similar to that of Figure
7.7, where the most attractive option is to use a toll producer. Again, as the
toll producer produces many enzymes and supplies to a number of industries,
they have the freedom to put out competitive prices. This shows in Figure 7.9,
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where it is more favourable to use a toll supplier to obtain enzyme than it is
to buy from a local producer who produces only FFase, or to produce FFase
within an scFOS production facility.
The ‘buy local’ and ‘self produce’ option show to be close at low production
levels but the curves part from each other more as the scFOS production levels
increase. The curves part because at low production levels for ‘buy local’, the
enzyme production facility will have to offer high enzyme prices to achieve a
30% IRR. At higher scFOS production levels, the enzyme production facility
is now selling more enzyme, so they can afford to drop their enzyme prices and
still achieve a 30% IRR.
Figure 7.9: ScFOS production that compares all the different options of obtaining
the AOX prodcued FFase enzyme, namely: through self-production, buying from a
local producer, buying from a toll supplier, and buying from a local producer that
can supply at a low export price.
Figure 7.10 shows the same information as Figure 7.9 but the lower scales of
production are focused on. It is more apparent in Figure 7.10 when comparing
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‘buy local’ and ‘self-produce’, ‘buy local’ becomes more attractive than ‘self-
produce’ at higher production levels for reasons already discussed. Looking at
‘export price’ and ‘buy local’, at low scFOS production levels, the export price
shows to be more favourable and the ‘buy local’ option needs higher enzyme
selling prices to be able to obatin a 30% IRR. When the scFOS production
scale increases the local supplier can afford to drop their prices as they move
towards the same price as the ‘export price’. This is shown in Figure 7.10
where the ‘buy local’ curve moves closer to the ‘export price’ curve.
Figure 7.10: ScFOS production that compares all the different options of obtaining
the AOX produced FFase enzyme, namely: through self-production, buying from a
local producer, buying from a toll supplier, and buying from a local producer that
can supply at a low export price.
All figures were plotted using Monte Carlo analyses and Figure 7.11 shows
the distributions for scFOS production for the given production scales with the
scenario of self-producing FFase using the AOX production strain for scFOS
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production. The mean from the curves from Figure 7.11 represents a point for
the information shown in Figure 7.4 for the AOX production strain.
Figure 7.11: IRR distribution from Monte Carlo analysis for scFOS production
scale (tpa) for the scenario of self-producing FFase using the AOX production strain.
Figure 7.12 shows the s-curves where cumulative probabilities are plotted
and it can be seen that for an scFOS production plant producing 2 000 tonnes
per annum, there is an 80% chance that the facility will achieve a 28.9% IRR
and there is a 44% chance that the facility will achieve a 40% IRR. Hacura
et al. (2001) say that in general, a project is relatively safe if the probability
of a negative outcome of NPV is less than 0.2. This statement can be related
to the scFOS production scenario of 2 000 tpa where there is 20% chance that
the IRR will be less than 28.9%.
Figure 7.13 shows a scenario where the scFOS selling price is varied in
conjunction with the scFOS production scale to determine what effect this
would have on the IRR. For 2 000 tpa of scFOS production, the facility can
afford to sell at USD6 to obtain 29.3% IRR or USD7 to obtain 35.5% IRR.
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Figure 7.12: S-curves which represent the cumulative probabilities of IRR for
scFOS production (tpa) for the scenario where FFase is self-produced in the same
facility as the scFOS production using the AOX production strain.
These would be recommended selling prices for the 2 000 tonnes per annum
production scale.
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Figure 7.13: The influence of scFOS selling price and scFOS production scale on
IRR for and scFOS production plant that produces only enough FFase (using AOX
production strain) for itself.
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Conclusions
The most significant findings from the objectives proposed in this project are
as follows:
• ScFOS can be produced on an appreciable scale in South Africa.
• A facility that produces only β-D-fructofuranosidase specifically for scFOS
production will have to sell its enzyme for R200/g of pure protein (using
AOX production strain) provided they produce 512 kilograms per annum
of β-D-fructofuranosidase (pure protein) in order for the production fa-
cility to succeed.
• Alternatively a facility that produces only β-D-fructofuranosidase spe-
cifically for scFOS production will have to sell its enzyme for R1 426/kg
of fermentation broth (using AOX production strain) provided they pro-
duce 72 tonnes per annum of β-D-fructofuranosidase (fermentation broth)
in order for the production facility to succeed.
• A facility that produces only β-D-fructofuranosidase specifically for scFOS
production will have to sell its enzyme for R349/g of pure protein (using
GAP production strain), provided they produce 562 kilograms per an-
num of β-D-fructofuranosidase (pure protein) in order for the production
facility to succeed.
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• Alternatively a facility that produces only β-D-fructofuranosidase spe-
cifically for scFOS production will have to sell its enzyme for R1 254/kg
of pure protein (using GAP production strain), provided they produce
95 tonnes per annum of β-D-fructofuranosidase (fermentation broth) in
order for the production facility to succeed.
• For a 2 000 tonnes per annum scFOS production plant, 14.43 tonnes of
enzyme fermentation broth (AOX production strain) is needed, which is
126 kg of pure enzyme.
• A single facility that produces β-D-fructofuranosidase (AOX production
strain) and scFOS for a 2 000 tonnes per annum scFOS production will
succeed having an IRR of 37.7%.
• The minimum production scale that scFOS can be produced while buying
FFase (AOX production strain) from a local producer and achieving an
IRR of 41.9% is 2 000 tonnes per annum.
• An scFOS production facility producing 2 000 tonnes per annum using
β-D-fructofuranosidase (AOX production strain) bought from a contract
toll enzyme manufacturer will show the best IRR rendering a value of
47.5%.
Other findings from this project that are also of useful knowledge are:
• When producing the enzyme β-D-fructofuranosidase, it is more favour-
able to use the AOX production strain compared to the GAP production
strain.
• The AOX produces a more concentrated enzyme compared to GAP so ef-
fectively the equipment cost will be less with AOX because less fermenter
space is needed.
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• Out of all the scenarios that were looked at, it is the most economical to
use a toll manufacturer to buy β-D-fructofuranosidase when producing
scFOS.
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Recommendations
The most practical manner in which to produce scFOS in South Africa would
be to manufacture β-D-fructofuranosidase and scFOS in the same facility. It
is more sensible to produce scFOS and β-D-fructofuranosidase in the same
facility as scFOS as there is a low FFase demand for the scFOS production
and therefore the required enzyme production equipment wouldn’t be excess-
ively large. Also because there is a low FFase demand for scFOS production,
the global market for the enzyme would not be high which means that there
wouldn’t be a lot of the enzyme available on the market. If there isn’t a lot of
enzyme available on the market, the likelihood is that the price of the FFase
will be high, which is another reason to self-produce FFase.
Another good option would be to implement a multi enzyme production
facility. A multi enzyme production facility should be the alternative where the
facility would aim to produce at least four different types of enzymes (FFase
to be one of them). This would work well because when regarding the capital
costs involved with enzyme production, the enzyme production processes are
similar for all the different enzymes. The main differences between the enzyme
production processes would involve the raw materials which are the running
costs where factors such as the production medium and cultivation conditions
will change. One has to remember that some enzymes may only be required
seasonally, which makes even more sense to employ a multi-product enzyme
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production facility.
Ultimately there are three options that can be taken from this project:
1. Implement an independent scFOS production plant in conjunction with
β-D-fructofuranosidase production that forms one process, producing 2
000 tonnes per annum of scFOS and selling at USD7 per kilogram of
scFOS.
2. Start up a multi enzyme production facility that will produce at least four
different enzymes, and this enzyme production facility will supply its β-
D-fructofuranosidase to an independent scFOS production facility. The
enzyme production facility will essentially be a local toll manufacturer.
3. Start up a multi enzyme production facility that will produce at least
four different enzymes (including FFase) and also include the scFOS
production process within the facility.
Stellenbosch University  http://scholar.sun.ac.za
Appendices
162
Stellenbosch University  http://scholar.sun.ac.za
Appendix A
Physical Data
Table A.1: Densities of Components in FFase Production
Component Density (g/ml) Reference
Biotin 1.41 WolframAlpha (2011)
Boric acid 1.44 WolframAlpha (2011)
Calcium sulphate 2.96 Linstrom et al. (1997)
Casamino acids 1.41 Berlin and Pallansch (1968)
Cobalt chloride 3.35 ChemicalBook (2008)
Cupric sulphate-5H2O 2.28 IowaStateUniversity (1995-2012)
Ferrous sulphate-7H2O 1.90 ChemicalBook (2008)
Glycerol 1.26 WolframAlpha (2011)
Magnesium sulphate-7H2O 2.66 IowaStateUniversity (1995-2012)
Manganese sulphate-H2O 2.57 WolframAlpha (2011)
85% Phosphoric acid 1.63 Egan and Luff (1955)
Potassium hydroxide 2.04 WolframAlpha (2011)
Potassium sulphate 2.66 ChemicalBook (2008)
Sodium iodide 3.67 ChemicalBook (2008)
Sodium molybdate-2H2O 3.28 ChemicalBook (2008)
Sulfuric acid 1.84 ChemicalLAND21 (2000-2010)
Water 1.00 Çengel and Cimbala (2006)
Zinc chloride 2.91 ChemicalBook (2008)
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Energy Data
Table B.1: Heat capacity data
Chemical
name
Molecular
formula
Molecular
weight
(g/mol)
Heat capa-
city (298K)
(J/mol.K)
Reference
Xylose C5H10O5 150 182.0 Hernández-Segura et al.
(2009), Goldberg et al. (1989)
Glucose C6H12O6 180 218.0 Douglas et al. (1951), Boerio-
Goates (1991)
Fructose C6H12O6 180 215.8 Finegold et al. (1989), Kawai-
zumi et al. (1981)
Sucrose C12H22O11 342 425.4 Anderson Jr et al. (1950), Put-
nam and Boerio-Goates (1993)
Kestose C18H32O16 504 662.5 Briggner and Wadsö (1990),
Hernández-Segura et al. (2009)
Nystose C24H42O21 666 805.1 Calculated from model
1F -F nystose C30H52O26 828 993.3 Calculated from model
α-cyclodextrin C36H60O26 972 1151.5 Briggner and Wadsö (1990),
Hernández-Segura et al. (2009)
GF5 C36H62O31 990 1181.5 Calculated from model
β-cyclodextrin C42H70O35 1134 1341.7 Briggner and Wadsö (1990),
Hernández-Segura et al. (2009)
GF6 C42H72O36 1152 1369.7 Calculated from model
GF7 C48H82O41 1314 1557.9 Calculated from model
Water H2O 18 75.4 Çengel and Boles (2007), Lin-
strom et al. (1997)
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Steam Tables
Table C.1: Steam Table (Spirax-Sarco, 2012)
Pressure (barg) Sat. temperature (◦C) Specific enthalpy (J/kg) Density (water) (kg/m3)
1 120.449 505725 942.793
2 133.705 562289 931.709
3 143.762 605453 922.801
4 151.966 640849 915.213
5 158.949 671117 908.527
6 165.059 697720 902.501
7 170.513 721561 896.984
8 175.451 743238 891.871
9 179.974 763168 887.091
10 184.154 781656 882.587
11 188.045 798931 878.320
12 191.691 815171 874.256
13 195.123 830515 870.369
14 198.368 845077 866.639
15 201.450 858947 863.048
16 204.384 872203 859.581
17 207.188 884907 856.226
18 209.873 897116 852.973
19 212.450 908873 849.812
20 214.930 920220 846.737
21 217.319 931192 843.739
22 219.626 941818 840.813
23 221.857 952125 837.953
24 224.017 962138 835.155
25 226.112 971876 832.415
26 228.145 981360 829.729
27 230.121 990605 827.092
28 232.044 999627 824.503
29 233.916 1010000 821.958
30 235.741 1020000 819.454
31 237.521 1030000 816.990
32 239.259 1030000 814.563
33 240.957 1040000 812.171
34 242.617 1050000 809.812
35 244.241 1060000 807.485
36 245.831 1070000 805.188
37 247.389 1070000 802.919
38 248.915 1080000 800.677
39 250.411 1090000 798.461
40 251.879 1090000 769.270
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Table D.1: Characteristics of equipment and operations used and compositions of
outlet streams (Vaňková et al., 2008)
Equipment Code Operation Duration
time (h)
T
(◦C)
Stream Composition (mass %)
Blending
tank
V-101 P1 1.5 25 F1 Salts 2.51, sucrose 24.63,
NaNO3 3.45, water 69.37
Bioreactor V-102 P4 80 28 F6 Biomass 7.32, FTase
0.0035, proteins 0.46, salts
2.69, sucrose 12.76, water
76.78
F9 FTase 0.0055, proteins
0.72, salts 4.24, sucrose
Microfilter F-102 P6 2.5 12 20.12, water 74.92
F12 Biomass 19.87, proteins
0.01, salts 0.03, sucrose
0.13, water 79.97
Table D.2: List of equipment used for the production of immobilised FTase
(Vaňková et al., 2008)
Name Description Cost/103 EUR
V-101 Blending tank, vessel volume 10m3 EUR 31
C-101 Compressor, power 400 kW 18.9
F-101 Air filter, rated throughput 0.06 m3 s−1 3.8
R-101 Fermenter (Bioreactor), vessel volume 10 m3 151
V-102 Blending tank, vessel volume 10 m3 31
F-102 Microfilter, membrane area 30 m2 26.5
Total 262.2
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Table D.3: List of raw materials for the production of immobilised FTase (Vaňková
et al., 2008)
Raw material Cost (EUR.kg−1) Amount (kg)
Sucrose 0.9 2500
Yeast extract 2.6 100
NaNO3 0.4 385
MgSO4.7H2O 0.5 25
K2HPO4 10.8 50
H2O 0.1 63000
NaCl 2.1 298
Resin DOWEX 124.4 3600
MARATHON MSA
Table D.4: List of equipment used for the production of FOS’s (Vaňková et al.,
2008)
Name Description Cost/103 EUR
R-102 Packed-bed reactor, volume 1.6 m3, 4 pieces 793
R-103 SMB column, volume 3.4 m3, 4 pieces 454
D-101 Spray dryer, evaporation 100 kg.m3.h−1 90
V-103 Blending tank, vessel volume 5 m3 27
Unlisted equipment 303
Total 1667
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Table D.5: Main categories of operation costs for production of FOS’s from food
sucrose (Vaňková et al., 2008)
Powdery
FOS’s/106
EUR
Percentage
(%)
FOS’s
syrup/106
EUR
Percentage
(%)
Raw materials 19.03 84.09 19.35 86.11
Consumables 1.40 6.19 1.37 6.10
Equipment-dependent 1.16 5.13 0.96 4.27
Utilities 0.72 3.18 0.48 2.14
Labour-dependent 0.16 0.71 0.16 0.71
Laboratory/QC/QA* 0.14 0.62 0.13 0.58
Waste treatment/disposal 0.02 0.09 0.02 0.09
Total 22.63 100 22.47 100
*QC - quality control, QA - quality assurance
Table D.6: Summary of costs for the production of FOS’s (Vaňková et al., 2008)
Powdery FOS’s FOS’s syrup
Total investment
costs/106 (EUR)
5.031 4.837
Food sucrose Industrial sucrose Food sucrose Industrial sucrose
Operation
costs/106 (EUR)
22.630 15.360 21.983 15.176
Production cost
(EUR.kg−1)
1.47 0.74 1.42 0.73
Production
cost/107 (EUR)*
1.47 0.74 1.42 0.73
* For an annual production of 10 000 tonne of FOS’s (Vaňková et al., 2008)
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Sample Calculations
E.1 Methanol Carry-over
Consider a scFOS production rate of 10 000 tonnes/year:
• The FFase production process, to meet a demand of 10 000 tonnes/year
production, will need 400 kg/h of methanol for a FFase fermentation
using the AOX production strain.
• If 90% of this methanol is consumed (which is a pessimistic assumption),
40 kg/h of methanol will go into scFOS process.
• The remaining 40 kg/h of methanol will be in the enzyme solution which
will enter the reactor in the scFOS process.
• the reactor product produces 3 630 kg/h of non-purified scFOS. Adding
the 40 kg/h of methanol 3 670 kg/h product flow rate.
• Enzyme percentage exiting the reactor would be 40/3 670, which will
equal of 1.1% (mass) of methanol.
• If the purification step in the scFOS process achieves 90%; 0.11% (mass)
of methanol will be present in final product.
• 0.11% (mass) equates to 1 100 ppm.
• This falls within acceptable range of 0.3% or 3 000 ppm.
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E.2 Spray drying air
The air flow rate for the industrial spray dryer was influenced by the work
done by Huang and Mujumdar (2007). Their study specified operating and
design parameter of a spray dryer.
• Feed rate: 1 200 kg/h (45% solids concentration) = 540 kg/h of solids
• Air inlet temperature: 250◦C
• Air outlet temperature: 110◦C
• Air mass flow rate: 3.5 to 5.5 kg/s
For an scFOS production rate of 2 000 tonnes per annum, the mass balance
was simulated to determine the incoming flow rate of scFOS syrup entering the
spray dryer. For 2 000 tonnes per annum of scFOS production, the incoming
stream (stream 5 in Figure 4.6 leaving the SMB chromatography column that
entered the spray dryer entered at a flow rate of 568 kg/h. The spray dryer
specifications for this design were:
• Feed rate: 568 kg/h (44.5% solids concentration) = 252.42 kg/h
• Air inlet temperature: 180◦C
• Air outlet temperature: 90◦C
• Air mass flow rate: 3.5 to 5.5 kg/s (average is 4.5 kg/s)
Therefore the incoming air mass flow rate that will remove the moisture
from the incoming scFOS ‘syrup’ stream will be:
568 ∗ 44.5% = 252.42 kg/h
Air flow rate = 4.5 ∗ 252.42/540
= 2.104 kg/s
= 7 563 kg/h of air needed
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F.1 FFase Production Process Material Stream
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F.2 ScFOS Production Process Material
Stream Tables
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Figure H.1: Industrial axial fan curves used to calculate the duty of a fan
(Ciclo Software, 2013).
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